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Abstract 
 
Legionellae are gram-negative bacteria, rod shaped, strictly aerobic and nutritionally 
fastidious. Legionella species are implicated in two clinical syndromes: Legionnaires’ Disease 
(LD), and Pontiac fever, which are collectively known as legionellosis. Among the 56 species 
and 70 serogroups of Legionella species, Legionella pneumophila is the major cause of 
sporadic and outbreak legionellosis (91.5%), and serogroup 1 is the predominant serotype 
(84.2%).  
Many studies have demonstrated that the main source for LD is the potable water systems in 
large buildings like hospitals and hotels. The contamination of hospitals' water systems with 
Legionella is high risk for patients with various diseases, especially immunocompromised and 
those who may stay hospitalized for long period of time.  LD is acquired by inhalation of 
aerosols contaminated with Legionella spp. or less commonly by aspiration of contaminated 
drinking water. 
Previous work in the Microbiology Research Laboratory at AQU has shown high prevalence 
of Legionella spp. in the water and biofilm samples collected from eight hospitals in the West 
Bank over a two-year period December 2012- December 2014, by using culture method and 
16S rRNA-based PCR. Moreover study of the prevalence of L. pneumophila in 195 
respiratory samples (sputum or Broncho alveolar lavage (BAL)) by culture yielded only one 
positive. However, by PCR, 23% (44/195) of the respiratory samples were positive for L. 
pneumophila. BAL presented a higher percentage 35% (26/74) than sputum 15% (18 /121).  
 Molecular diagnosis of L. pneumophila is well established and adopted worldwide especially 
that culture methods are time consuming and less efficient. Furthermore, genotyping of L. 
pneumophila is important for epidemiological investigation and control of legionellosis 
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outbreaks. The current gold standard for L. pneumophila genotyping is Nested PCR Sequence 
Based Typing (NPSBT), based on the sequence of seven loci (flaA, pilE, asd, mip, mompS, 
proA and neuA). NPSBT allows the Sequence Typing (ST) of L. pneumophila in the absence 
of isolates. This high-resolution molecular typing tool is recommended by the European 
Working Group for Legionella Infections (EWGLI).  
The previous results in the Microbiology Research Laboratory entitled the use of NPSBT to be 
able to do epidemiological typing of the respiratory samples in the absence of isolates and to 
relate the ST’s of environmental samples previously collected from the same hospital with the 
ST of the respiratory samples to evaluate possible nosocomial infection. 
The overall goal of this study was to determine the Sequence types (ST’s) of the PCR positive 
respiratory samples by NPSBT method. Also to determine the ST’s of the environmental 
samples obtained from the same hospital ward. 
Our sample study included a subset (34 samples) out of the 44 respiratory samples previously 
tested positive by PCR targeting 16S rRNA for L. pneumophila.  These thirty-four positive 
samples were further subtyped by NPSBT method. Also DNA previously extracted from 15 
biofilm samples previously collected from Makassed hospital wards and tested positive for L. 
pneumophila was also analyzed  by NPSBT.  
Analysis of the seven allele profiles for the NPSBT of the 34 selected respiratory samples 
showed a full 7-allele profile for 3 /34 (8.8 %) specimens, a further 18/34 (52.9%) gave 5- or 
6-allele profiles (sufficient to identify the strain as one or two sequence types (ST’s), 6/34 
(17.6%) gave 3- or 4-allele profiles (usually enough to differentiate different profiles), and 5 
/34 (14.7%) gave 1- or 2-allele profiles (sufficient to distinguish strains). Overall, 24/34 
(70%) samples gave ≥ 4 alleles profiles (4, 5, 6 and 7 alleles). However, 10 samples gave < 4 
alleles profiles, these samples were excluded from sequencing in order to identify the ST. 
Analysis of the seven alleles’ products of the selected fifteen environmental samples revealed 
fourteen samples positive for six to seven alleles and one sample was positive for one allele, 
this sample was excluded from sequencing in order to identify the ST 
 Sequence analysis showed the following ST’s in the 24 respiratory samples: ST1 (29.1%, 
7/24), ST 461 (25%, 6/24), ST 1037 (4%, 1/24), and (41.9%, 10/24) gave incomplete profile.  
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On the other hand, 14 environmental samples typing showed: ST 1(28.6%, 4/14), ST 187 
(21.4%, 3/14), one sample of each ST 2070, ST 461 and ST 187 (7.1 %, 1/14), while the rest 
of samples (28.5%, 4/14) were unspecified Sequence Types. 
Thus ST1 is the most prevalent sequence type in both the respiratory samples and the 
environmental samples representing 29.1% and 28.5% respectively. The other ST’s were 
unique to each type of sample. ST1 is also the most prevalent ST worldwide in clinical and 
environmental samples.  
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Chapter One 
 
1.1 Introduction 
 
The year 2016 marked forty years since legionellosis has been discovered back in 1976. 
Legionellosis is a collection of infections that are caused by Legionella spp. bacteria, ranging 
from a self-limited febrile illness (Pontiac fever) to a severe and fatal form of pneumonia 
Legionnaires’ disease (LD). LD can affect any individual but usually affects those who are 
more susceptible due to immunosuppression, illness, age, and other risk factors, such as 
smoking (Phin et al., 2014).  
Legionellae are gram-negative bacteria, rod shaped, strictly aerobic and nutritionally fastidious 
(Napoli et al., 2010). Among the 56 species and 70 serogroups (Sgs) of Legionella species 
(Tijet et al., 2010), Legionella pneumophila is the major cause of sporadic and outbreak 
legionellosis (91.5%), and serogroup 1 is the predominant serotype (84.2%) (Nathalie Tai et al., 
2012).   
L. pneumophila is the second most common pathogen in industrialized countries related with 
cases of community-acquired pneumonia that requires patient admission to intensive care units 
(Tijet et al., 2010). 
Legionella spp. are ubiquitous in freshwater habitats, including natural occurring and man-
made water, such as rivers, lakes, streams, ponds, hot springs, and subsurface waters, and are 
naturally part of microbial ecosystems (Fliermans et al., 1981; Fliermans, 1996b; Qin et al., 
2013). 
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The potable water systems in large buildings like hospitals and hotels are considered the main 
source for LD (Fraser, et al., 1977), and the contamination of hospitals' water systems with 
Legionella is high risk for patients with various diseases, who may stay hospitalized for long 
period of time. It is well known that LD is an important cause of hospital-acquired pneumonia 
(Fraser et al., 1977; Kool et al., 1999). 
L. pneumophila is the most frequently isolated Legionella species from water distribution 
networks and is also the one predominantly associated with disease (Fields et al., 2002). 
 
1.2 History 
 
In the summer of 1976, the Centers for Disease Control and Prevention (CDC) in Atlanta, 
responded to a sudden, explosive epidemic of febrile illness with pneumonia among attendees 
of the American Legion conference in Philadelphia, Pennsylvania (Sharrar et al., 2002).  
The cause of the Philadelphia outbreak was unknown for months in spite of determined 
laboratory examination for heavy metals. More than 77 known pathogens and culture on more 
than 25 different media for bacteria were examined without success (McDade et al., 1977). An 
epidemiologic analysis determined that the disease most likely was airborne and primarily 
focused at one convention hotel, which later had to be closed because of adverse publicity 
(Fraser et al., 1977). After six months, Joseph McDade and co-worker announced that they had 
discovered the etiologic agent, a fastidious Gram-negative bacillus namely L. pneumophila. 
(McDade et al., 1977). 
The source of infection was believed to be the air conditioning system at the conference hotel. 
However, no clear proof of the mode of transmission was obtained. Thirty-four (15%) 
individuals died from 221 who were infected. After the isolation of Legionella bacteria the 
epidemiological scientists tried to solve earlier outbreaks with the same symptoms (McDade et 
al., 1977), the first was in Washington, DC, in 1965, where 14 of 81 infected individuals died 
(McDade et al., 1977; Thacker  et al., 1978), and the second was a non- pneumonic outbreak 
that occurred in Pontiac, MI, in 1968, where no deaths were reported among 144 cases 
(McDade et al., 1977; Glick et al., 1978).  
3 
 
 
Over the years several new serogroups of L. pneumophila and other Legionella spp. have been 
discovered (Travis et al., 2012;  Pravinkumar et al., 2010; Casati  et al., 2009; Currie et al., 
2014). Currently, there are more than 56 known species comprising 70 distinct Sgs (Tijet et al., 
2010). Fifteen Sgs of L. pneumophila have been described (Pearce et al., 2012; Muder et al., 
2002). 
After these outbreaks the surveillance systems and control were evaluated and improved to 
manage any future outbreak in many countries including USA, Japan, Europe, Australia, New 
Zealand (Phin et al., 2014). However there is no surveillance for Legionella spp. in most Arabic 
country including Palestine.  
 
1.3 Bacterial characteristics 
 
Legionellae are Gram-negative, aerobic, non-spore-forming and motile rods belonging to the 
gamma- proteobacteria (Molofsky and Swanson, 2004), They are not related to other bacteria 
except for Coxiella burnetii (Swanson and Hammer, 2000). 
The bacterium is considered as pleomorphic in shape, influenced by temperature, available 
nutrients or metabolites, growth environment (e.g., inside amoebae), and medium type. 
Legionellae appear as coccoid or bacillary (0.3- to 0.6-m by 3-m), and/or long filamentous (8- 
to 50-m) forms (Rowbotham, 1986; Greub and Raoult, 2003; Katz et al., 1984). 
The documentation of Legionella species and serogroups (Sgs) increased after the first 
outbreak. Legionella species and serogroups associated with human disease are shown in (Table 
1.1) (Benson and Fields, 1998;Fields et al., 2002). 
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Table 1.1: Legionella species and serogroups associated with human disease  
 
 
 
Legionellae are urease-negative, catalase-positive, heterotrophic, aerobic, chemo-organ trophic, 
and transitionally motile. When motile, they have one or more straight or curved polar or lateral 
flagella. Legionellae have different biphasic life cycle that alternates between a non-motile, 
replicative phase and a virulent, flagellated, trans-missive phase (Garrity et al., 2005; 
Rowbotham, 1980). When cultured in the laboratory, Legionellae normally have one polar 
flagellum in the stationary phase (Swanson and Hammer, 2000). 
Different from most bacterial species, Legionellae use protein for energy source rather than 
carbohydrates, several amino acids are metabolized, especially serine and threonine, which are 
the main sources of energy (George et al., 1980; Tesh et al., 1983). Legionellae utilize amino 
acids for energy and carbon, do not oxidize or ferment carbohydrates, and require L-cysteine-
HCl and iron salts for growth amongst other nutrients (Garrity et al., 2005).  Sodium chloride 
(NaCl) is inhibitory to planktonic Legionellae in water and stationary phase cells recovered 
from samples (Swanson and Hammer, 2000; Garrity et al., 2005). 
Legionellae can grow on different types of artificial media such as buffered charcoal yeast 
extract medium (BCYEα), pH 6.9. It is the medium of choice for culturing L. pneumophila, 
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although it might not be the most favorable for some non-L. pneumophila species (Edelstein,  
1981a; Edelstein, 1983b).  
Legionellae are strict aerobes. When Legionella pneumophila is cultured on laboratory BCYEα 
media it grows equally well with air and in a microaerophilic environment. Reduced O2 tension 
has however been shown to be favorable under some conditions (Mauchline et al., 1992; 
Dennis et al., 1984). However, the addition of CO2 in the medium does not stimulate growth, 
except possibly for some non-L. pneumophila species (Edelstein, 1983). The optimum 
temperature is 35 - 37ºC, but some growth can also be observed in the laboratory at 42°- 43ºC 
(Dennis et al., 1984; Kusnetsov et al., 1996; Ohno et al., 2003).  
Since Legionellae are able to grow and retain metabolic activity in high temperatures over 
50ºC, it is conceivable that they might also multiply at temperatures higher than 43ºC in natural 
environments, e.g. in biofilms and intracellularly in amoebae (Ohno et al., 2003). 
The cell wall of Legionellae unlike most gram-negative bacteria contains long, branched 
hydroxyl fatty acids that are unique for the family. The difficulty of cell staining is influenced 
by ubiquinone's with side chains of 9-14 isoprene units in fatty acid chain in the cell wall 
(Garrity et al., 2005). Also the polysaccharide epitopes of the lipopolysaccharide in the cell wall 
are specific and can be used for serological grouping (Helbig et al., 1996).  
L. pneumophila is the most Legionella spp. studied because; approximately 90% of all 
Philadelphia outbreak cases of LD were caused by L. pneumophila Sg 1 (Benin et al., 2002; Yu 
et al., 2002). L. pneumophila Sg 1 accounts approximately 90% of American and European 
Legionella isolates. However in Australia and New Zealand, L. pneumophila Sg 1 accounts for 
only 50% of the cases of community acquired legionellosis, whereas L. longbeachae accounts 
for approximately 30% of the cases (Yu et al., 2002).  
 
1.4 Environmental investigations   
 
Legionellae bacteria are aquatic organisms that live in freshwater environments (Fliermans et 
al., 1981).  L. pneumophila has been cultured and recovered from both natural and human-made 
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habitats, from lakes and streams to air-conditioning cooling towers, fountains, and spa baths 
(Lettinga et al., 2002; Molmeret et al., 2004; Morris et al., 1979). But L. longbeachae are the 
exception and differ from the ecological niche of L. pneumophila which resides primarily in 
soil, and infection is often associated with exposure to soil (Steele et al., 1990). Legionella 
bacteria are not free-living aquatic bacteria; rather, this bacterium needs an environmental host 
to live within as a parasite or form a commensal relationship with free-living, freshwater, and 
soil amoebae (Steinert et al., 1997). 
Legionella species multiply intracellularly in many types of protozoa, and this relationship is 
central to the ecology of the organism in both aquatic and soil environments. While providing a 
niche for Legionella replication, amoebae also protect Legionella from hard environmental 
conditions. This relationship between Legionella and amoeba can increase the resistance to 
biocides, antibiotics, acid, osmotic and temperature stress (Cirillo et al., 1994a; Cirillo et al., 
1999b), Furthermore, some amoeba species expel biocide-resistant vesicles containing large 
numbers of L. pneumophila bacteria, which may act as airborne agents for the transmission of 
the bacteria (Berk et al., 1998).  
In human-made water systems, such as in buildings and hospitals water systems, Legionella 
bacteria are found almost exclusively within complex biofilms (Rogers, et al., 1994). Also in 
this ecosystem the characterization of Legionella is difficult, but biofilm systems have 
demonstrated that the replication of L. pneumophila within this biofilm depends on the presence 
of an amoeba host (Murga et al., 2001).  
LD is most strongly associated with human-made aquatic environments that contain water at 
high temperatures. Instead, many disease outbreaks are linked to cooling towers and 
evaporative condensers, which can produce water droplet contaminated with L. pneumophila 
that are inhaled (Newton et al., 2010).  
The increased presence of Legionella reservoir such as human-made aquatic reservoirs has 
likely led to the increased exposure of humans and unfortunately to increased incidence of 
Legionella infection in the latter half of the 20th century.  
The pathogenesis of LD is largely due to the ability of L. pneumophila to invade and grow 
within macrophages in the lungs (Rowbotham, 1986). Therefore, the evolution of virulence 
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traits in L. pneumophila has resulted largely from the organism’s need to replicate in an 
intracellular host and also avoid predation by environmental protozoa (Newton et al., 2010). 
Protozoa are considered its natural host in water environments. Legionella are able to survive 
phagocytosis and multiply inside protozoan cells. Infections result with lysis of the protozoan 
host and the release of Legionella into the media, where it can be found in its free-living form 
or associated with biofilm. Elevated temperature, inorganic and organic contents of the water 
and the presence of host protozoa, play key roles in Legionella growth and spread (Fliermans et 
al., 1981). 
 
1.5 Ecology 
 
Legionella spp. are ubiquitous in freshwater habitats, including rivers, lakes, streams, ponds, 
hot springs, and subsurface waters, and are naturally part of microbial ecosystems (Fliermans et 
al., 1981; Qin et al., 2015; Ortiz-Roque and Hazen, 1987).  However,  potting mixes and soil 
are considered an important source for infection with L. longbeachae which was recovered 
from potting mixes in Australia, United States, and the United Kingdom and in the soil of Thai 
farmland (Travis et al., 2012;  Pravinkumar et al., 2010; Casati  et al., 2009).  
Many studies have proved the ability of these bacteria to infect and multiply within amoebae in 
their environment (Declerck, 2010; Declerck et al., 2007; Sheehan et al., 2005). Today it has 
become clear that Legionella are adapted to live, proliferate and replicate within different 
protozoan genera, including Acanthamoeba, Naegleria, Hartmannella, and Tetrahymena 
(Taylor et al., 2009). This is very important in Legionella life cycles to induce virulent bacterial 
traits, assist in distribution, and provide protection from harsh or bactericidal environmental 
conditions, such as excessive heat and chlorine (Berk et al.,2008; Hojo et al., 2012; Neumeister 
et al., 2000; Bigot et al., 2013).  
Legionellae spp. can live in different water temperatures in cold and hot water at (25°C to 
37°C) but may replicate and proliferate at temperatures above and below this range and may 
even survive at growth-restrictive temperatures of 20°C and 55°C (Arvand et al., 2011). 
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Also, they are found growing in the biofilm that lines the inside of pipes (Fields et al., 2002). 
Additionally, some parts of water distribution systems are especially prone to contain 
Legionella, like blind loops, plumbing fixtures, showers, whirlpool spas, and cooling towers 
(Rogers et al., 1994).   
 
1.6 Mode of transmission  
 
Different modes have been identified for transmission of Legionella to humans; Legionellosis is 
transmitted via the airborne route when aerosols are inhaled from a water source contaminated 
with the bacteria, there is evidence for aerosolization, aspiration, or even instillation into the 
lung during respiratory tract manipulation (Stout and Yu, 2003). Legionellosis may be very 
rarely transmitted from person to person (Amodeo et al., 2009; Lindsay et al., 2012). 
LD is a respiratory illness caused by inhalation of Legionella-containing aerosols generated by 
showers, faucets, air conditioning cooling towers, whirlpool spas, and fountains (García-
Fulgueiras et al., 2003; Bennett et al., 2014), and other aerosols formation devices. Aspiration 
of water containing Legionella has also been suggested to be a common transmission route (Yu, 
2001). Figure (1.1). 
Many studies on the mode of transmission including aspiration have been suggested by some 
authors to be more important than inhalation (Yu, 1993; Pedro-Botet et al., 2002). 
Susceptibility to disease is associated with smoking, older age, chronic cardiovascular or 
respiratory disease, diabetes, alcohol misuse, cancer especially profound monocytopenia as 
seen in hairy cell leukemia, and immunosuppression (Boer et al.,2006), especially, in higher 
risk individuals such as hospitalized patients and immunocompromised. If the tap water 
contains L. pneumophila, the bacteria could possibly be instilled directly into the lung of a 
patient (Tablan et al., 2003).  
In numerous studies, the risk of LD disease was significantly greater for patients who 
underwent endotracheal tube placement more often or had a significantly longer duration of 
intubation than for patients who had other causes of pneumonia. Use of sterile water for all 
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nasogastric suspensions, for humidifiers in breathing circuits of mechanical ventilators, and for 
flushing tubes has been recommended to prevent Legionella infection (Fields et al., 2002).  
LD due to L. longbeachae is thought to have a different route of transmission, which is yet to 
be fully identified, but exposure to potting compost or soil, or gardening activities is regarded 
as a risk factor (Amodeo et al., 2009; Lindsay et al., 2012). Poor hand washing practices after 
gardening, long-term smoking, and being near dripping hanging flowerpots have also been 
associated with a greater risk (O'Connor et al., 2007).    
Inhalation or micro-aspiration of amoebae could be a potential risk, since one single amoeba 
might harbor >1000 legionella cells (Rowbotham, 1980).  Furthermore, intracellular growth in 
Acanthamoeba castellanii affects monocyte entry mechanisms and enhances the virulence of L. 
pneumophila. Thus, it is conceivable that infection in humans may require the presence of both 
Legionellae and an amoeba host (Swanson and Hammer, 2000). This could explain why the 
attack rate in LD outbreaks is low, despite the presence of Legionellae in the plumbing system. 
In one study occurrence of LD cases was related to the presence of both protozoa and L. 
pneumophila (Breiman et al., 1990). 
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Figure 1.1: Modes of Legionella dissemination from natural waters to development of Legionnaires’ 
disease and/or Pontiac fever. Legionella from freshwater sources (1) is distributed at low concentrations 
from points of water purification (2) to colonize downstream local plumbing networks and cooling 
systems (among other sites) (3) and amplifies under permissive environmental conditions (4). 
Subsequent aerosolization (5) exposes a human population, which may include individuals with 
increased susceptibility (6), leading to a potential disease spectrum. More susceptible individuals (due to 
age or underlying medical conditions) are at a higher risk of LD than those less susceptible, and both 
groups are at risk for Pontiac fever. The route of LD caused by contaminated soil is less well understood 
but also appears to involve aerosol exposure. (Adapted from Mercante and Winchell, 2015). 
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At the same time, the problem is particularly important in hospitals, where the medical 
equipment can also be a potential source of infection (Endoscopes, devices for artificial 
respiration and oxygen therapy, dental devices, etc.) (van Heijnsbergen et al., 2015).  
 
1.7 Clinical features 
 
It is clear that LD classically presents as two distinct clinical entities, pneumonia with severe 
multisystem disease, and Pontiac fever, a self-limited flulike illness.  
The symptoms of Legionnaires’ are similar to those of other types of pneumonia. LD does not 
have specific, defining clinical features because it presents as a range of clinical 
manifestations and symptoms, undetected cases of LD end up being classified merely as 
pneumonia and are effectively treated with a broad spectrum antibiotic (Viasus et al., 2013; 
Levy et al., 2010; Cunha, 2008). 
 
Most of the LD patients present with fever, non-productive cough, headache, myalgia and 
dyspnea. Clinical syndromes may include diarrhea, nausea, vomiting, liver and kidney 
dysfunction, thrombocytopenia, hyponatremia and neurological disorders (Fields et al., 2002; 
Zarogoulidis et al., 2011), and also may include: fever with organ-specific symptoms and signs, 
such as diarrhea or confusion, or both; fever with multisystem disease including 
rhabdomyolysis with renal failure; pneumonia with extra pulmonary features; and severe 
fulminant disease (Chidiac et al., 2012)  
LD pneumonia has no particular clinical feature that clearly distinguishes it from other types 
of pneumonia (De Jong et al., 2013), and laboratory investigations must be carried out to 
confirm the diagnosis for appropriate and successful management of the disease. It normally 
takes between 2 and 10 days to develop symptoms (Den Boer et al., 2002). Patients usually 
start with a dry cough, fever, headache and sometimes diarrhea and many develop pneumonia. 
People over the age of 50 years are at higher risk than younger people, and males are at higher 
risk than females (Phin et al., 2014). 
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The incubation period of Legionnaires’ ranges from 2–10 days (average 6–7 days); but also 
may be longer or shorter (Den Boer et al., 2002; Greig et al., 2004),  However, in some cases 
the incubation period of 19 days was noted in one outbreak (Den Boer et al., 2002). 
 
Conversely, a mild, self-limiting, and non-pneumonic form known as Pontiac fever has also 
been associated with exposure to aerosols containing Legionella spp. The incubation period of 
Pontiac fever is short (between 5 and 66 h but usually 24–48 h) and duration (2–5 days), and is 
more common in younger people (Tossa et al., 2006). 
 
A mortality rate is typical in most people ranging from 8–12% but might be higher in people 
who are at higher risk including: elderly, have preexisting medical conditions, smokers, are 
nosocomial cases, or have a delay in diagnosis and treatment of their disease (Dominguez et 
al., 2009). The average case-fatality rate is 10% in Europe (range 0–27% in countries 
reporting ≥30 cases) and 8% in the USA. Also the case-fatality rate in nosocomial cases is 
higher and ranges between 15% and 34% (Beauté et al., 2013; Control, C. f. D., and 
Prevention, 2011). 
Unfortunately the high mortality and morbidity associated with untreated LD was noted and 
reported (Stout and Yu, 2003). 
1.8 Diagnosis 
 
LD disease is perceived as rare because most cases are never detected, and not all detected 
cases are reported to public health authorities and most of the cases occur sporadically. Since 
the clinical signs and symptoms for LD are not specific, prompt and accurate laboratory 
diagnosis is crucial, for the successful management and treatment (Phin et al., 2015). 
 
A case of LD will go undetected unless special laboratory tests are performed.  Unfortunately, 
these tests are not routinely available in many countries.  In the USA some hospitals have 
recognized cases of Legionnaires’ disease only after increased testing of patients with 
pneumonia. Likewise, in hospitals where only one to three cases of LD were identified over 
several months, numerous additional cases were recognized after surveillance was intensified. 
Studies of community-acquired pneumonia have also indicated that increased surveillance 
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leads to better diagnoses (Fields et al., 2002). 
 
The methods for detection of Legionella were developed year by year. Confirmed methods 
used to test this bacterium include specific culture, serology, urinary antigen test and direct 
fluorescent antibody screening. Some of these methods are too slow for clinical use and or 
inadequately sensitive or specific (Ginevra et al., 2009). Thus molecular methods were 
evaluated to increase the specificity and sensitivity in clinical diagnosis of LD and early 
detection and management (Figure 1.2). 
 
 
Figure 1.2: Samples and diagnostic methods : In this figure we can see many of the samples and 
diagnostic tests for detection of Legionella pneumophila. Some assays are applicable to multiple 
specimen types, such as culture and nucleic acid amplification. In general, the success of detecting 
Legionella is dependent on the severity of the disease, specimen integrity, technical proficiency of the 
laboratory, and particular test characteristics. (Adapted from Mercante and Winchell, 2015)  
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For epidemiological investigation of LD, the identification of Legionella spp. and serogroups 
is not sufficient. It is important to use subtyping methods, which discriminate between the 
strains at the molecular level 
 
1.8.1 Microbiological culture 
 
Culture and isolation remain to this time the “gold standard” for Legionella identification and 
LD diagnosis. Using specimens from the lower respiratory tract, such as sputum, pleural fluid, 
bronchial aspirates, and bronchial alveolar lavage (BAL) fluid (Fields et al., 2002). However, 
due to the specific nutrient requirements of Legionella, it requires some special growth factors 
and special media. 
Legionellae can grow on different types of artificial media; but, the most successful medium is 
buffered charcoal yeast extract (BCYE) agar containing 0.1% α ketoglutarate with L-cysteine 
incubated at 35°C in a humidified, 2.5% CO2 atmosphere (Feeley et al., 1979). 
The sensitivity of detection of Legionella by culturing of clinical specimens is highly variable, 
ranging from >10% to 80%, and recovery is dependent on the sample type as well as the 
experience and technical proficiency of laboratory personnel (Reller et al., 2003). Most 
isolates demonstrate growth in 3 to 5 days, but non-L. pneumophila Legionella species and 
occasionally primary-specimen isolates may require considerably longer incubation times, 
sometimes up to 2 weeks (Control, C. f. D., and Prevention report, 2005). Culture yield 
depends on the severity of illness, with the lowest yield from 15% to 25% in mild pneumonia 
and the highest yield more than 90% for severe pneumonia causing respiratory failure (Reller 
et al., 2003). 
Although for enhancing Legionella recovery, one can use semi-selective procedures in the 
presence of competing bacteria (from clinical and environmental samples), including brief 
acid and heat exposure and/or the addition of glycine, Polymyxin B, Cycloheximide, and 
vancomycin to the growth media, to which Legionellae are naturally resistant. Most 
Legionellae are cysteine auxotroph's (the exceptions being L. oakridgensis, L. jordanis, and L. 
nagasakiensis, all of which may adapt to cysteine-deficient media after serial passage 
(Orrison, et al., 1983; Yang et al., 2012). 
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1.8.2 Urinary antigen test 
 
Legionella urinary antigen tests (UAT) are significantly quicker than culture and have a high 
sensitivity and specificity, showing a positive detection of >90% of cases in under 15 minutes 
of incubation .The antigen can become present in the urine in as little as 1 to 3 days after 
symptomatic onset, representing 82% and 97% of the diagnostic tools used for LD 
confirmation in Europe and the United States, respectively (Control, C. f. D., and Prevention 
report, 2011). 
The popularity and ubiquity of the UAT are attributed to its speed, relatively low cost, 
uncomplicated procedure, and ease of sample collection. Legionella specific urinary antigens 
can be detected in the majority of L. pneumophila infections shortly after clinical symptoms 
appear (2 to 3 days) and may be excreted for several days to 10 months, even during antibiotic 
treatment and after disease resolution (Jarraud et al., 2015). 
The most significant problem with the UAT is that it is specific only to L. pneumophila 
serogroup 1, therefore a positive test indicates LD, but a negative test cannot rule it out.   
 
1.8.3 Serological and antibody-based assays 
 
For detection of L. pneumophila, the serological testing for IgG and IgM antibodies against 
Legionella in blood serum was critical in the original Philadelphia outbreak investigation 
(Beauté et al., 2013), and one of the principal methods used for LD diagnosis in the early 
1980s.  The number of serological tests used in the clinical laboratory has decreased 
significantly with the rise of standardized culture media, techniques and more definitive 
analyses such as the rapid urine antigen test and molecular methods (Benin et al., 2002). 
  
 In Europe the use of serology for LD diagnosis and confirmation decreased from 61% to 6% 
on average in the period from 1995 to 2010. According to the European Centre for Disease 
Prevention and Control (ECDC) and the World Health Organization (WHO), displaced by the 
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more fast, less technically demanding UAT (Beauté et al., 2013; World Health Organization 
report, 1997). 
 
There are different reasons for this change; the serological methods indirect fluorescent 
antibody test and Enzyme linked Immunosorbent Assay (ELISA) for detecting patient 
seroconversion depend on a 4-fold increase in anti-body titer (to 1:128) between acute- and 
severe-phase serum samples taken 4 to 8 weeks apart, which means that the window for 
treatment has long passed (Edelstein, 1987). 
 
Other tests such Direct fluorescent antibody test (DFA) assays, slide agglutination tests 
(SATs), and Monoclonal Antibody (MAb) screens are antibody based but the patient serum is 
not directly tested. For the SATs and MAb test, a pure-culture isolate is needed. DFA assays 
can be performed on cultures, patient tissues, or fluid secretions. However, their use for 
Legionella respiratory antigen detection in clinical laboratory was decreased to minimal, from 
a rate of 1% in 1996 to 1/10 of 1% in 2010 (Beauté et al., 2013). 
 
DFA assays, SATs, and MAb blotting are useful for qualitative Legionella identification and 
for Legionella typing at the species and serogroup levels. The tests benefit from being 
relatively rapid, inexpensive, and reliable, allowing strain comparisons across time with 
commercially available reagents (Edelstein, 1987), but similar to the Indirect Fluorescent 
Antibody (IFA) assay, they require a moderate-to-high level of laboratory expertise 
 
1.8.4 Nucleic acid-based molecular diagnostics  
 
Since Legionella are difficult to culture and the sensitivity of the culture is variable and highly 
dependent on the laboratory technical skills, molecular methods that are 100 percent sensitive 
and rapid were sought. In the mid-1980s Nucleic acid-based research for Legionella detection, 
diagnostic and typing began (Mercante and Winchell, 2015).  
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The first use of Polymerase Chain Reaction (PCR) as a tool for Legionella detection came in 
1989, at Stanford University when researchers had combined PCR with Southern blot to detect 
Legionella DNA in water (Starnbach et al., 1989). The development of PCR-based strategies 
continued into the 1990s for epidemiological studies with environmental samples, also 
evaluated and validated this powerful new method in a variety of matrices, including water 
from cooling towers, rivers, and hot tubs as well as sputum, BAL fluid, serum, and urine 
(Yamamoto et al., 1993; Fry et al., 1991; Jaulhac et al., 1992). In the early 2000s Real-time 
PCR was used for quantitative and monitoring of L. pneumophila. 
The benefits of Nucleic Acid Amplification Tests (NAATs) are high sensitivity and 
specificity, and rapid turnaround time. NAATs such as conventional PCR, and real-time PCR 
(single and multiplex) protocols have been developed for Legionella detection and 
characterization. Most NAAT-based assays are highly specific (close to 100%), and the 
growing consensus is that the sensitivity of PCR (both conventional and real time) is equal to 
or greater than that of culture-based detection using specimens from the lower respiratory tract 
or environmental water samples (Jespersen et al., 2009). Detection may be superior for 
diagnosing milder LD cases or detecting prior exposure. The most common targets include a 
conserved segment of the rRNA genes for the 5S and 16S subunits, the 16S-23S spacer, and/or 
the macrophage inhibitor protein mip, found primarily in the genus Legionella and highly 
conserved in all L. pneumophila isolates. Also the ssrA  gene is target (for all Legionella 
species), and wzm for L. pneumophila serogroup 1(for Lp1) genes ((Mercante and Winchell, 
2015). 
 
In addition to detection and diagnosis, NAATs are commonly used for Legionella typing, 
mainly in conjunction with traditional MAb or serology 
 
1.9 Typing of Legionella 
 
In epidemiological studies the detection and identification of Legionella bacteria is not enough, 
therefore scientists developed methods with more discrete discrimination for further subtyping  
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Many subtyping methods can be used on Legionella pneumophila bacteria; pulsed-field gel 
electrophoresis (PFGE), restriction fragment length polymorphism (RFLP), ribotyping, 
arbitrarily primed PCR (AP-PCR), repetitive element PCR (rep-PCR), amplified fragment 
length polymorphism (AFLP) analysis, and phylogenetic comparison of various Legionella 
species- and strain specific genes, including ftsZ and sidA , among others (Gilmour et al., 2007; 
Gomez-Lus et al., 1993;  Ratcliff, 2013).  
Subtyping methods of L. pneumophila strains are considered the most discriminatory methods 
for typing and subtyping however they require isolates (Fry et al., 2002). PCR and RT-PCR 
performed directly from clinical specimens were evaluated for the diagnosis of LD and 
showed high sensitivity and specificity (Mercante and Winchell, 2015). 
 
In the past few years, epidemiological techniques have been developed to be used directly 
with clinical samples by PCR-based typing methods such as; Multiple locus variable tandem-
repeat (MLVA) assays are based on the separation and sizing of short to long tandem repeated 
sequences.  Sequence Based Typing (SBT) is a powerful method based on the sequencing of 
seven gene loci and is recognized as the new EWGLI (European Working Group for 
Legionella Infections) gold standard tool for L. pneumophila typing (Fields et al., 2002; 
Pancer, 2013). 
 
1.9.1 Nested PCR Sequence Based Typing (NPSBT) 
 
 SBT methods are considered the gold-standard methods for L. pneumophila genotyping for 
epidemiological studies and investigations based on multi locus sequence typing (Gaia et al., 
2003a; Gaia et al., 2005b; Ratzow et al., 2007). SBT-based strain discrimination depending on 
the sequences of seven-gene named  (flaA,  pilE,  asd,  mip,  mompS,  proA,  and neuA ), with 
the option of including a neuA homologue (neuAh) if the standard SBT primers fail to amplify 
the target in non-sg1 strains. Direct sequence comparison is very important advantage for SBT 
methods, which eliminates the interpretational subjectivity of non-sequence-based methods 
such as PFGE, which are prone to banding ambiguities over time or between laboratories 
(Scaturro et al., 2005).  
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The European Society for Clinical Microbiology Study Group on Legionella Infections 
(ESGLI) (formerly the European Working Group on Legionella Infections [EWGLI]) maintains 
an allele database (currently version 3.0) that allows querying of large sets of raw sequence 
data, delivering both an allelic profile and a final combined sequence type (ST) for each isolate. 
The database is dynamic and continually updated with the addition of new allele sequences and 
STs. 
SBT is performed on DNA extracted from culture isolates; although, many studies have 
demonstrated some success when SBT was performed directly on nucleic acids extracted from 
clinical samples such as BAL or Sputum (Ginevra et al., 2009; Coscollá and González-
Candelas, 2009), however, SBT when used on culture-independent samples varies widely with 
sample origin (e.g., sputum versus BAL fluid) and quality and also is typically much lower than 
that of pure isolate extractions.  
Laboratory expertise and the use of high-quality media can maximize bacterial growth from 
otherwise low-quality samples, yet if an isolate is not obtained because of prior antibiotic 
therapy or suboptimal shipping and storage, culture-independent SBT offers a potentially 
viable alternative (Mercante and Winchell, 2015). 
 
DNA sequence based molecular typing techniques are becoming more and more popular.  
Sequence based typing have several advantages such as the speed of data generation from 
DNA (i.e., not living strains but DNA can be sent to reference laboratories), unambiguous and 
highly reproducible nature of data, additive nature of data (data for "eternity"), highly portable 
data (electronic intra- and inter-laboratory exchange), easy storage of data in searchable 
databases, easy usage of a standardized nomenclature (central expanding databases) and 
straight-forward phylogenetic reconstructions from data (Mercante and Winchell, 2015).  
 
Recently, Ginevra et al., (2009), applied SBT methods directly on 63 clinical samples and the 
efficiency of SBT, was very poor and provided only 3.6% the complete sequencing data. To 
solve this problem and to increase the sensitivity of SBT when directly performed on clinical 
samples this group newly designed sets of seven primers that are external to the seven existing 
ones that are already used for Legionella SBT.  This new SBT named as Nested-PCR-based 
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SBT (NPSBT) technique has improved the sensitivity of SBT when applied directly to the 
same respiratory samples. The results showed that NPSBT significantly improved 
epidemiological typing 17– fold compared to the initial SBT when applied directly to clinical 
samples. NPSBT gives rapid and robust discriminatory epidemiological data, in particular 
when no isolates are available. 
 
NPSBT represents an excellent tool for L. pneumophila subtyping, in particular when no 
isolates are available. NPSBT has an important advantage over SBT for Legionella 
epidemiological investigations because the rapid identification of the source of infection, can 
allow prompt implementation of environmental control measures to prevent further 
legionellosis cases (Scaturro et al., 2011). 
 
1.10 Literature review 
 
Legionella is an important cause of mostly adult pneumonia and it must be actively considered 
in both community – acquired and nosocomial pneumonia (Touray et al., 2014).  LD was 
named after the 1976 outbreak in Philadelphia, Pennsylvania  (McDade et al., 1977),  after this 
first outbreak the attention and the awareness has increased. Surveillance schemes for LD was 
placed in some countries such as USA, Canada,  Europe, Japan, Australia and New Zealand,  
However in most countries LD is under recognized because of lack of awareness of medical 
personnel and lack of routine microbiological testing for Legionella in the hospital 
bacteriological laboratories (Phin et al., 2014).  
 
LD outbreaks occur each year in the United States and affect 10,000 to 20,000 cases based on 
The Centers for Disease Control and Prevention (CDC) (Arora et al., 2012). 
Large outbreaks of LD have been associated with contaminated cooling towers, hot and cold 
water systems, and whirlpool spas. Indeed Cruise ships can be sources of Legionella for 
similar reasons and have been associated with outbreaks of LD (Phin et al. 2014). 
Although sporadic outbreaks of the disease occur throughout the year, most of the epidemics 
of Legionella infection occur in late summer and autumn, presumably because the organism 
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proliferates in water reservoirs during the warm months. A large outbreak at a flower show in 
the Netherlands was traced to the whirlpool spas, which were used in the exhibits (Arora et al., 
2012). 
Furthermore, beside the community acquired LD, LD has been recognized as an important 
cause of hospital-acquired pneumonia, Micro-aspiration is the major mode of transmission in 
hospital-acquired LD (Sabria and Victor, 2002). 
Nosocomial LD has become increasingly common, contributing up to 30 percent of hospital-
acquired pneumonias in some institutions.  LD usually is acquired by inhalation or aspiration 
of Legionellae from contaminated environmental sources (Borella et al., 1999). Potable water 
is an important source of both nosocomial and community acquired Legionella infections 
(Fields et al., 2002).  Nosocomial LD is an important problem in some hospitals in the world. 
It has been estimated that 20–30% of legionellosis are nosocomial infections and that they are 
associated with a contamination of the hospital’s water distribution system (Tai et al., 2012). 
Thacker et al., (1975) reported the first outbreak of hospital-acquired LD in a psychiatric 
hospital in Washington DC in 1965, 81 patients were reported with pneumonia, with 15 
deaths. Retrospective studies on stored serum samples showed antibody seroconversion for L. 
pneumophila in 85% of the patients  
Borella et al., (1999) reported a single case of nosocomial legionellosis was discovered in a 
1000 bed hospital in Milan, Italy. The hospital’s first case of hospital acquired LD was a 29 
year old man., he died the next day and Legionella was identified by immunofluorescence in 
lung tissue. The environmental surveillance revealed that the centralized hot water distribution 
system of the hospital was colonized with L. pneumophila. Shock heating and hyper-
chlorination of water was applied, which reduced the number of contaminated sites in the 
short term, but water was recolonized two months later. During the period of active 
surveillance from January 1998 to September 1999, six nosocomial cases were identified. In 
addition, 12 community cases were discovered. 
The largest outbreak of hospital-acquired LD occurred at the Wadsworth Veterans’ 
Administration Medical Center (VAMC) in Los Angeles, from 1982 to 1985, and the potable 
water supply was the actual source of hospital acquired LD (Sabria and Victor,  2002). 
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Now, it is well known that the potable water system is a major source of infection by 
Legionella in hospitals; Wellinghausen et al., (2001) studied the contamination of hospital 
water systems with Legionella at three different hospitals belonging to the University of Ulm 
in Germany between October 2000 and February 2001. A total of 77 potable water samples 
were collected. The rates of detection of Legionella were 70.1% (54 of 77). 
In Palestine the hospitals water systems are also contaminated with L. pneumophila based on a 
previous study by Shareef et al., (2008) and a more recent study in our laboratory in which a 
two-year (December 2012 – December 2014) proactive environmental surveillance of L. 
pneumophila in the water distribution systems of eight hospitals in the West Bank was carried 
out. All the water sources tested positive for the presence of Legionella with 8.3% prevalence 
for the water samples (n=72) by culture and the prevalence rate increased to 50% (n=72) by 
PCR. Testing biofilms, the prevalence of L. pneumophila was much more prevalent being 
16.8% (n= 1136) by culture and increasing to 61.3% ( n=225) by PCR. 
For the conformation of nosocomial acquired LD in hospitals, different methods can be used, 
but when no isolates are available as pure colonies the molecular methods such as SBT and 
Nested-SBT are considered as a gold standard method. Luck et al., (2008) reported a LD case 
for a 66-year-old man who was hospitalized at the University Hospital of Berlin in 2004. 
Eighteen days later, he was readmitted to the intensive care unit of the same hospital with a 3-
day history of fever, also the patient had received a cadaveric kidney transplant 4 months 
earlier. A Broncho alveolar lavage fluid (BAL) collected on day 2 after admission was 
positive for L. pneumophila-species antigen by direct immunofluorescence mAb staining. Four 
months after developing Legionella pneumonia he died of multi-organ failure. Environmental 
samples were taken from the hospital and home water supplies, the results of AFLP and SBT 
typing confirmed that the clinical strain and environmental isolates from the patient’s home 
were indistinguishable. This is a strong argument for the transmission from the patient’s home 
water supply. 
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1.11 Problem statement 
 
Since water environments (naturally occurring and man- made water) are the major reservoirs 
for L. pneumophila, this is a huge problem when the Legionella bacteria are present in hospital 
water systems. The serious health risk to hospital staff and the patients is a well-known risk 
factor for hospital-acquired pneumonia (Benin et al., 2002).  
 The Microbiology Research Laboratory at Al-Quds University investigated the prevalence of 
Legionella spp. in environmental samples, and showed high prevalence of Legionella spp. in 
the Palestinian water environment collected from eight hospitals by using culturing methods 
and PCR. Regarding the clinical prevalence of L. pneumophila, 121 sputum and 74 Broncho 
alveolar lavage specimens (n=195) collected from suspected pneumonia patients in the West 
Bank, from September 2014 till June 2016, were cultured for L. pneumophila and genomic 
DNA was extracted and tested by PCR amplification for L. pneumophila 16S rRNA gene. Only 
one out of 195 cultured respiratory specimens was positive for L. pneumophila. The very low 
yield by culture maybe very much related to the heavy antibiotic use in Palestine prior to 
hospital admission. By PCR, 44/195 (23%) of the respiratory samples were positive for L. 
pneumophila. Bronchial lavage presented a higher percentage 35%, (26/74) than sputum, which 
revealed 15% (18/121) positive.  
These results are the first evidence for the presence of L. pneumophila in clinical samples 
collected from suspected pneumonia patients from Makassed Hospital in Palestine. In this study 
we took the research project a step further analyzing the L. pneumophila PCR positive BAL and 
sputum samples by NPSBT in order to identify the ST’s in the respiratory samples and to 
compare these ST’s with the ST’s of L. pneumophila PCR positive environmental DNA 
samples obtained from the same hospital. 
 
1.12 Goals 
 
The main goal of this study is SBT of L. pneumophila by using Nested PCR sequenced based 
typing method. NPSBT is the best method available to determine the sequence type of 
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Legionella directly from clinical samples in the absence of isolates and to compare the 
sequence types in the study sample with those in the EWGLI data base. Finally to try to 
determine possible nosocomial infection by comparing the sequence types from clinical 
samples with the sequence types of environmental isolates obtained from patient’s wards in 
Makassed hospital. 
 
1.13 Questions 
 
1. How do the ST’s of L. pneumophila in Palestine compare to other countries? 
2. How do the Sequence types of the clinical samples compare to the Sequence types of 
the environmental samples. 
3. What is the possible source of infection? 
 
1.14 Hypothesis 
 
L. pneumophila is present in water systems in Palestinian hospitals, and it is very important to 
take action regarding surveillance of water systems for Legionella spp.  
Legionella are opportunistic bacteria that cause a fatal form of an atypical pneumonia for 
hospitalized and immunocompromised patients, as well as community acquired pneumonia. L. 
pneumophila is the cause of up to 90% of clinical cases and serogroup 1 is the cause of 84% of 
those cases (Yu, 2001a; Yu et al.,  2002b).  
Previous work in the laboratory tested 195 clinical specimens obtained from suspected 
pneumonia patients by culture methods and by molecular methods (PCR). The identification by 
culture yield was very low, one positive sample out of 195 samples tested, most likely due to 
the overuse of antibiotics in Palestine. By PCR the yield was much higher (23%). However in 
order to do an epidemiological study we need to do subtyping at the DNA level. Since Nested 
PCR-derived SBT method is highly recommended and can be applied to respiratory samples 
from patients with legionellosis directly (without the need for an isolate) we set out to test and 
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analyze the clinical samples (sputum or BAL) collected from suspected pneumonia patients 
from Makassed hospital for L. pneumophila. Specimens that tested positive by PCR for L. 
pneumophila were subtyped by using Nested-PCR-SBT. This typing is based on the sequences 
of seven gene loci (flaA, pilE, asd, mip, mompS, proA, and neuA), and comparing those 
sequences with the allele database of EWGLI (Ginevra et al., 2009). 
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  Chapter Two 
 
2.  Methodology 
 
 
 
2.1 Inclusion criteria 
 
The clinical samples were collected from suspected pneumonia patients presenting to Makassed 
Hospital in Jerusalem in the period between September 2014 and August 2015, after signing a 
written informed consent form (see Appendix A) and ethical approval from Al-Quds University 
and the Hospital’s Ethical Committee and the Palestinian Health Research Council/ Helsinki 
Committee (PHRC/HC/211/17). 
 
2.2 Research place 
  
The research was carried out at the Microbiology Research Lab, Al-Quds University, towers 
building B, 6
th
 floor, Abu Dies, Jerusalem. 
27 
 
 
 
2.3 Sample collection 
2.3.1 Clinical samples 
 
Broncho Alveolar Lavage (BAL) samples (n=74) and sputum samples (n=121) were collected 
at Makassed hospital from suspected pneumonia patients. The samples were stored at 4°C until 
received by the Microbiology Research Lab at Al-Quds University within 48 hours. 
2.3.2 Environmental samples 
 
The environmental samples (water  from (faucet and  shower) and biofilm) had been collected 
from Makassed Hospital previously, and the microbiological (culture) and molecular (PCR) 
analyses for L. pneumophila had been performed in the Microbiology Research laboratory at 
Al-Quds University (Zayed, 2013). 
 
2.4 Sample preparation 
2.4.1 Culture method 
 
Total samples  (Sputum  and BAL samples)  were treated thermally (56°C for 10 min) and 
then inoculated onto GVPC (Glycine-Vancomycin-Polymyxin-Cycloheximide; BD, United 
States) Legionella selective media. Plates were incubated at 37 ºC for 7 days. Five colonies of 
each positive sample were selected and re-isolated on GVPC plates. Identification as 
Legionella spp. was confirmed by the ability to grow on GVPC and inability to grow on blood 
agar (M073, HI media, India) (L-cysteine free) plates. Positive samples were re streaked on 
BCYE and further identified by an agglutination test using (Legionella Latex Test, Oxoid 
DR0800M, England) according to manufacturer’s instruction. The test allows a separate 
identification of L. pneumophila serogroup 1, serogroups 2-14 and of detection of seven 
Legionella species (L. non- pneumophila). 
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2.4.2 Molecular method 
2.4.2.1 DNA extraction from sputum and BAL samples 
 
The BAL or sputum samples were stored at 4°C until processed. Each sample was vortexed at 
room temperature for 10 seconds and 1-2 ml of each sample was transferred to a fresh sterile 
tube. Genomic DNA was extracted from each BAL and sputum sample by using DNA 
extraction kit (Qiagen, 69506,Germany).  
Briefly, 2 ml of BAL and 1 ml of sputum was centrifuged at 17000xg for 10 minutes then the 
pellet was suspended in 250 ul of sputum lysis buffer (20 mM Tris-HCl, 2 mM EDTA, 1.2% 
Triton X-100 (9002-93-1, Sigma- Aldrich, Germany) [pH 8.0]) containing 10 mg/ml lysozyme 
(62970, Fluka, Sigma-Aldrich, Switzerland) with 250 ul of molecular grade water (Promega, 
USA), then incubated at 37
o
C for 30 minutes (with shaking at 1500 rpm). The samples were 
centrifuged at 17000x g for 15 minutes, and then the supernatant was discarded. 180ul of ATL 
buffer was added with 20 ul of proteinase K (15mg/ml) and incubated at 56
 o
C
 
for 1 hour (with 
shaking at 1500 rpm), then 200ul of AL buffer was added to the sample and incubated at 70
o
C 
for 10 min, then 200 mml of ethanol (96-100%) was added and mixed by vortexing,  the 
samples were loaded onto the spin column and centrifuged at 17000x g for 1 minute, then 
500ul of AW1 buffer was added and centrifuged at 6000x g for 1 min, then 500 ul of AW2 
buffer was added then centrifuged at 17000x g for 3 minutes, then the spin column was placed 
in a new 2 ml collection tube and 100 ul of AE buffer or distilled water  was added then 
centrifuged at 6000x g. Extracted DNA was stored at -80
o
C   
 
2.4.2.2 Environmental samples  
 
We used extracted DNA from the 15 environmental samples (water (cold and hot), and 
biofilm), which were collected from faucets and showers from different departments at 
Makassed Hospital, and processed previously by the Microbiology Research Lab, Al-Quds 
University (Zayed, 2013). 
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2.5 Positive controls   
 
DNA of Legionella as shown in (Table 2.1) kindly provided by (Prof. Manfred Höfle, HZI, 
Braunschweig, Germany) was used as DNA control in this study. 
  
Table 2.1: Legionella reference strains 
 
 
 
 
 
 
2.6 Negative control 
 
Molecular grade water (Promega, USA) was used as negative control in 16S rRNA PCR and 
the Nested Sequence Based Typing PCR. 
 
 
2.7 Polymerase Chain Reaction  
2.7.1 PCR for  respiratory samples  
 
PCR was used for identification of L. pneumophila species in BAL and sputum samples. PCR 
L. pneumophila species (L1) primers were purchased from (hylabs, Park Tamar, 76326 
Rehovot, Israel) to amplify PCR product of 544bp. The primer sequences are shown in (Table 
2.2). Their location on the complete genome of 16s rRNA of L. pneumophila 
subsp.pneumophila ATCC 43290 is shown in (Fig. 2.1). Some of the clinical samples were 
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previously analyzed in Microbiology Research laboratory at Al-Quds University, for 
identification of L. pneumophila by PCR.  
 
AccuPower ®  HotStart PCR Premix was used for PCR amplification;  to each AccuPower ® 
Hot Start PCR Premix tube, a mixture of 0.8ul (10mmol) forward primer (L1F), 0.8ul 
(10mmol) reverse primer (L1R), and 4ul (100ug/ml) DNA template  was distributed into the 
each Premix and 14.4 ul molecular grade water (Promega, USA), were added. PCR 
amplification was done on thermal cycler (1861096, Bio-Rad, USA) per the following 
conditions: predenaturation at 94°C for 5 minutes followed by 35 cycles of denaturation at 
94°C for 45 seconds, annealing at 55°C for 60 seconds, elongation at 72°C for 45 seconds and 
final elongation at 72°C for 5 minutes. DNA of L. pneumophila  (AUG2013 (4pg) was used as 
positive control and Molecular grade water (Promega, USA) was used as negative control. 
PCR products of 544bp were analyzed by agarose gel electrophoresis. 
 
2.7.2 PCR for environmental samples  
  
The detection of L. pneumophila in environmental samples was done previously in the 
Microbiology Research laboratory (Zayed, 2013). 
 
Table 2.2: Primers used in the study 
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Figure 2.1: L. pneumophila whole genome and primers location (Dr. Manfred Höfle,, HZI) 
 
2.8 Molecular typing methods 
2.8.1 Nested PCR Sequence Based Typing  
 
NPSBT was used to obtain typing data for L. pneumophila from BAL and sputum samples. 
Typically DNA extracts from respiratory samples previously demonstrated to be positive for 
the presence of L. pneumophila by PCR targeting 16S rRNA were used as the starting 
material.  
The procedure according to European Working Group for Legionella Infections (EWGLI) , 
Nested -SBT (version 2.0) was applied (Mentasti and Fry, 2012). 
(http://www.hpabioinformatics.org.uk/legionella/legionella_sbt/php/sbt_homepage.php).The 
NPSBT method includes two rounds of PCR; the first round of PCR is carried out with 7 
primer pairs (flaA, pilE, asd, mip, mompS, proA, neuA) (Table 2.3), which bind externally to 
those used in the second round PCR for another 7 primer pairs (Table 2.4) 
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Table2.3 : First round NPSBT amplification primers (Adapted from Mentasti and Fry, 2012) 
 
 
 
 
 
 
 
 
 
 
Table 2.4 : Second NPSBT amplification primers  ( Adapted from Mentasti and Fry, 2012)          
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2.8.2 First round PCR reaction 
 
In the first round PCR, DNA samples which were positive by 16S rRNA targeting L. 
pneumophila were used as starting material. PCR amplification was performed in a total 
volume of 20 μl. PCR plate was placed on a cold block, PCR mix was started by adding 4 
μl of Taq DNA polymerase Mix to each PCR tube (Table 2.5), then 11 μl of the Master 
Mix was added (Table 2.6), finally the DNA template (5 μl) was added. The negative 
control received (5 μl of nuclease free water (Promega, USA) and the positive control 
received 5 ul of L. pneumophila DNA. The Pipetting of solutions was done in the 
following order; test samples, negative control, and lastly positive control (Mentasti and 
Fry, 2012). 
Table 2.5: Taq polymerase mix                                         
 
Table 2.6: Reaction Master Mix  
 
Volume/reaction 
(μl) 
Final concentration Reagents 
7.1 μl   Nuclease-free water 
1.1μl 1 X PCR buffer 
0.4 μl 2.5 mM MgCl2 
1 μl 10 pmoles Nested Primer F 
1 μl 10 pmoles Nested Primer R 
0.4 μl 200μM DNTPs 
11.0 μl   Volume/reaction 
 
 
 3.4 μl  Nuclease-free water
 0.4 μl  PCR buffer (x10)
 0.2 μl  Taq DNA polymerse (5U/μl)
 4.0  μl  Volume/reaction
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2.8.3 Thermal cycler parameters  
 
PCR amplification was performed using thermal cycler (1861096,Biorad, USA) according 
to the following conditions: initial denaturation at 95°C for 5 minutes followed by 40 
cycles of denaturation at 95°C for 30 seconds, annealing at 50°C for 30 seconds, 
elongation at 72°C for 60 seconds and final elongation at 72°C for 10 minutes (Table 2.7) 
(Mentasti and Fry, 2012).  
 
Table 2.7: Thermal cycler conditions for first round. 
 
 
 
        
2.8.4 Second round PCR reaction 
 
The PCR products from the first round PCR were used as starting material for the second 
round. 
PCR amplification was performed in a total volume of 20 μl, PCR plate was placed on a 
cold block. PCR mix was started by adding 4 μl of Taq DNA polymerase Mix to each 
PCR tube (Table 2.5), Then 11 μl of Master Mix was added to each tube (Table 2.6), with 
using second specific primers. Finally 5 μl from each of the completed PCR reaction mix 
from the first round was used as starting template. The tubes/plates were spun briefly in a 
centrifuge before placing them in a thermocycler heating block. The pipetting of solutions 
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was done in the following order, test samples, negative control and lastly positive control. 
 
2.8.5 Thermal cycler parameters for second round 
 
PCR amplification was performed using thermal cycler (1861096,Biorad, USA) according 
to the following conditions: initial denaturation at 95°C for 5 minutes followed by 35 
cycles of denaturation at 95°C for 30 seconds, annealing at 55°C for 30 seconds, 
elongation at 72°C for 60 seconds and final elongation at 72°C for 10 minutes (Table 2.8) 
(Mentasti and Fry, 2012). 
 
Table 2.8: Thermal cycler conditions for the second round 
 
 
2.9 Agarose gel preparation and electrophoresis  
 
The 1.5 % agarose gel was prepared by dissolving 3g agarose (A9539, Sigma Aldrich, 
Germany) in 200 ml 1X TAE electrophoresis buffer (0.04 M Tris-Acetate, pH 8.0 and 
0.001M EDTA), boiled in the microwave, and when it cooled to 50°C, 5l of ethidium 
bromide (1 g/ml) (hylabs, Israel) was added. The PCR products were analyzed on 
horizontal gel electrophoresis (Multisub, Biocom, Germany). The applied voltage was 120 
volts for one hour 
 
2.10 DNA Sequencing 
 
After performing gel electrophoresis on the PCR products from the second round, the 
positive Nested PCR products were sent to hylabs, Israel, for purification and sequencing 
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and the second round primers were used as sequencing primers. Sequencing results were 
submitted to the online Legionella SBT Quality Tool  
www.hpa-bioinformatics.org.uk/cgibin/legionella/sbt/seq_assemble_legionella1.cgi. 
which was used to assign individual allele numbers. For each isolate, the combination of 
seven alleles was defined as a seven-digit allelic profile by using the predetermined order 
flaA, pilE, asd, mip, mompS, proA, and neuA (e.g., 1-4-3-1-1-1-1) and a sequence type 
(ST) represented by a number (e.g., ST1).  
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Chapter Three 
 
3. Results 
 
 
3.1 Samples   
3.1.1 Sample study (Inclusion criteria) 
 
This study included respiratory samples (n=195); 74 BAL and 121 sputum samples 
collected from suspected pneumonia patients that were hospitalized at Makassed Hospital, 
in the period between September 2014 and August 2015. 
3.1.2 Patients’ data 
 
The study included 75 female patients, twenty two of them (29.3%) were positive for L. 
pneumophila by PCR targeting the 16SrRNA and 120 of male patients, twenty-two of them 
(18.3%) were positive for L. pneumophila by PCR targeting the 16SrRNA. The age of the 
patients ranged between 3 months and 86 years. Patients were hospitalized in different 
departments; internal medicine, pediatric, intensive care unit (ICU), ICU pediatric, cardiac 
care unit (CCU), surgery and gynecology (see Appendix B) 
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3.2 Detection of L. pneumophila in respiratory samples 
3.2.1 Cultivation dependent analysis 
 
A total of 195 respiratory samples (74 BAL and 121 sputum samples) were tested by 
cultivation dependent analysis by plating on GVPC Legionella selective media  (Glycine –
Vancomycin – Polymyxin, Cycloheximide; BD, United States). Only one of the total 195 
samples was positive for L. pneumophila by routine bacteriological culture method. This 
very low yield may be explained due to the regimen of antibiotics heavily used by patients 
prior to hospitalization. 
 
3.2.2 Cultivation independent analysis  
3.2.2.1 Detection of L. pneumophila in respiratory samples by PCR using 16S rRNA (L1 
primer) 
 
DNA extracted from 195 respiratory samples, 121 sputum and 74 BAL samples collected 
from suspected pneumonia patients presenting to Makassed hospital in Eastern Jerusalem 
were screened for the presence of L. pneumophila using (L1 primer) 16S rRNA PCR. L1 
primer gives PCR product 544bp as shown in figure (3.1) 
 
 
 
 
 
 
 
 
39 
 
 
 
Figure 3.1: Representative 16S rRNA PCR using L1 primer of DNA extracted from the 
respiratory samples; Lane 1 represents 100bp ladder (M). Lane 2 represents positive control  (P) 
DNA of cultured L. pneumophila. Lane 3 (N) represents negative control (Molecular grade water 
(Promega, USA). Lanes 4 to 10 represent clinical respiratory samples, lane 4, 5, 7, 8, 9 and10 
represent positive samples showing a 544bp band.  
 
 
3.2.2.2.1 The prevalence of L. pneumophila in respiratory samples 
 
PCR analysis of 195 respiratory samples for L. pneumophila revealed (44/195) 23% 
positive and (151/195) 77% negative in all (sputum and BAL) samples targeting 16S rRNA 
specific for L. pneumophila (Figure 3.2).  
Lanes         (1)         (2)         (3)         (4)           (5)         (6)         (7)         (8)          (9)          (10) 
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Figure (3.2): Prevalence of L. pneumophila in respiratory samples by PCR targeting 16S rRNA 
(L1 primer). 
 
3.2.2.2.2 The prevalence of L. pneumophila in sputum Vs. BAL samples 
 
PCR analysis of sputum samples (n=121) for L. pneumophila (L1 primer), showed 18 
(15%) positive and 103 (85%) negative samples, In contrast, the PCR analysis of BAL 
samples (n=74)  for  L. pneumophila  (L1 primer), showed 26 (35%) positive and 48 (65%) 
negative samples (Figure 3.3). 
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Respiratory Samples 
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Figure 3.3: The prevalence of L. pneumophila in sputum vs. BAL samples using PCR targeting 
16S rRNA (L1 primer). 
 
3.2.2.2.3 The distribution of L. pneumophila positive samples from pneumonia patients 
according to hospital department 
 
The largest number of positive samples was in patients hospitalized in, internal medicine 
ward (36.3%), followed by patients from pediatric wards each (25%), followed by patients 
from ICU ward with (22.7%), followed by surgery (9%), ICU pediatric (4.5%) and 
gynecology (2.3%) wards. (Figure 3.5).  
 
3.2.2.2.4 The distribution of LD patients according to age 
 
The largest number of patients with legionellosis was under 20 years of age with 15 cases 
(34 %), 6 cases (13.6%) were between 20-40 years, 10 cases were between 41-60 years 
(22.7%), and 13 cases above 60 years (29.5 %) Figure (3.6). 
 
 
0
5
10
15
20
25
30
Sputum BAL
18/121 
(15%) 
26/74 
(35%) 
42 
 
 
 
Figure 3.5: The distribution of L. pneumophila positive samples (n=44) by PCR according to 
hospital department 
 
 
Figure 3.6: The distribution of L. pneumophila positive samples (n=44) by PCR, from 
pneumonia patients according to age. 
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3.2.2.2.5 The distribution of patients with legionellosis according to Gender 
 
Twenty two males were positive for L. pneumophila by PCR out of 120 total males with 
(18.3%), in contrast, twenty two females were positive out of 75 total females with ( 
29.3%). 
 
Table  (3.1): The distribution of L. pneumophila positive samples (n=44) by PCR  according to 
gender. 
 
 
 
3.3 Molecular typing of L. pneumophila in respiratory samples by Nested PCR sequence 
Based Typing (NPSBT)  
 
Out of 44 samples positive for L. pneumophila by 16S rRNA PCR, 34 clinical samples 
which contains sufficient quantity were selected and processed for Nested PCR Sequence 
Based Typing method according to EWGLI standard scheme as explained in materials and 
methods. 
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Seven PCR tubes (one for each targeted gene) were prepared for each sample. In the first 
round, PCR primers flanking the targeted gene of interest (flaA, pilE, asd, mip, momps, 
proA and neuA) were used. The PCR products from the first round were used as starting 
material for the second PCR set, in which primers targeting the genes (flaA, pile, asd, mip, 
momps, proA and neuA) were used. PCR products of second round were analyzed by gel 
electrophoresis, Figure (3.8). 
 
In addition, 15 environmental samples obtained from the different wards of Makassed 
hospital which were collected and analyzed previously by the Microbiology Research 
laboratory were also typed by Nested PCR Sequence Based Typing molecular method. The 
aim is to compare the Sequence types obtained for the respiratory samples, with the 
Sequence types of the environmental samples to find any nosocomial correlation. 
PCR products of both clinical and environmental samples were purified and sequenced in 
Hy Laboratories Ltd (hylabs), sequencing results were submitted to the “Sequence Quality 
Tool” 
(www.hpa-bioinformatics.org.uk/cgi-bin/legionella/sbt/seq_assemble_legionella1.cgi).  
which was used to assign individual allele numbers. For each isolate, the combination of 
seven alleles was defined as a seven-digit allelic profile by using the predetermined order 
flaA, pilE, asd, mip, mompS, proA, and neuA (e.g., 1-4-3-1-1-1-1) and a sequence type 
(ST) represented by a number (e.g., ST1).  
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Figure 3.8: Gel electrophoresis for seven alleles’ products of the second round PCR; M is 
100pb ladder, section A is the positive control for the seven alleles flaA,  pilE, asd, mip, mompS, 
proA,  and neuA, section B represents BAL specimen (S10), section C represents BAL specimen 
(M6,) section D represents the negative control for this experiment.  
 
3.3.1 Nested PCR for respiratory samples  
 
Analysis of the allele profile (number of positive bands seen in the gel) for the nested PCR 
of 34 selected samples showed 24 positive with ≥ 4 positive bands (4, 5, 6 and 7 bands), 
however, 10 samples gave < 4 positive bands, these samples were excluded from 
sequencing, (Figure 3.1). (see Appendix C). 
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Figure 3.9: The number of samples with ≥ 4 bands (alleles) shown in gels of second round 
PCR for respiratory samples.  
 
Table (3.1) illustrates the percentage of positive alleles amplified by Nested PCR in 
respiratory samples pilE allele was the highest amplified allele with 85.2% of the thirty four 
samples, followed by flaA and mompS with 61.7%, then mip allele (58.8%), asd and neu 
with  (55.8%), and finally the lowest amplified allele was proA with 50% of the 34 samples. 
 
Table (3.2) Number of positive alleles and percentage in respiratory samples 
 
Allele  Number of alleles 
amplified 
Number of  
alleles not 
amplified 
% positive  
flaA 21/34 13/34 61.7% 
pilE 29/34 5/34 85.2% 
Asd 19/34 15/34 55.8% 
Mip 20/34 14/34 58.8% 
mompS 21/34 13/34 61.7% 
proA 17/34 17/34 50 % 
neuA 19/34 15/34 55.8% 
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3.3.2 Nested PCR for environmental samples  
 
Analysis of gel electrophoresis for seven alleles’ products of the second round PCR for the 
selected fifteen environmental samples revealed fourteen samples were positive for six to 
seven alleles (bands), and one sample was positive for one allele, this sample was excluded 
from sequencing. (Figure 3.10). (see Appendix c). 
 
 
Figure 3.10: The number of samples with ≥ 6 bands (alleles) shown in gels of second round 
PCR for environmental samples. 
  
Table (3.2) illustrates the percentage of positive alleles, which were amplified by Nested-
PCR in the environmental samples. The alleles’ amplification in Nested-PCR of the 
environmental samples were higher than the amplification in clinical samples. The 
percentage of amplification of flaA, pilE, asd, mip, and mompS alleles was (93.3%) of all 
fifteen samples, followed by proA and neu with (86.6%) amplified. 
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Table (3.3) Number of positive alleles and percentage in the environmental samples 
 
Allele  Number of  
alleles amplified 
Number of 
alleles not 
amplified 
% positive  
FlaA 14/15 1/15 93.3% 
PilE 14/15 1/15 93.3% 
Asd 14/15 1/15 93.3% 
Mip 14/15 1/15 93.3% 
Momps 14/15 1/15 93.3% 
ProA 13/15 2/15 86.6% 
Neu 13/15 2/15 86.6% 
 
3.4 Sequence type distribution:  
3.4.1 Sequence type distribution in respiratory samples  
 
Twenty-four BAL samples that were positive for four, five, six or seven alleles by Nested 
PCR were sequenced, the sequence files were submitted to (www.hpa-
bioinformatics.org.uk/cgi-bin/legionella/sbt/seq_assemble_legionella1.cgi).  Website to get 
the Sequence Types, (Figure 3.12).  
After submission of data files, the sequence types were; ST1 (29.1%), ST 461 (25%), ST 
1037 (4.7%), and 41.9% incomplete profile.  ST 1 was the most predominant sequence 
type in clinical samples (Figure 3.11). ( see Appendix D).  
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Figure 3.11: The distribution of Sequence Types (STs) for respiratory samples.  
 
3.4.2 Sequence type distribution in environmental samples 
 
Fourteen environmental samples were sequenced after Nested PCR analysis the sequence 
files for the alleles were submitted to (www.hpa-bioinformatics.org.uk/cgi-
bin/legionella/sbt/seq_assemble_legionella1.cgi).  to determine the Sequence Types.  
The results of Sequence Types of environmental samples resulted in five different sequence 
types; ST 1(28.5%, 4/14), ST 187 (21.4%, 3/14), one sample of ST 2070, ST 461 and ST 
187 (7.1 %, 1/14), while the rest of samples (28.5%, 4/14) were unspecified Sequence types. 
The most prevalent ST in the environmental samples is ST1, Figure 3.8. (See Appendix D). 
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Figure 3.12: The distribution of Sequence Types (STs) for environmental samples from 
Makassed Hospital. 
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Chapter Four 
 
4.1 Discussion 
 
 
 
This study reports the results of the first attempt to identify L. pneumophila in respiratory 
samples obtained from pneumonia patients, thus diagnosing legionellosis in Palestinian 
patients from Makassed hospital. The singularity of the current study is that it used high 
specific and sensitive molecular methods to identify Legionella in BAL and sputum 
samples and NPSBT applied directly to clinical specimens for Sequence typing in the 
absence of isolates.  
NPSBT allows the epidemiological typing and comparison with EWGLI Sequence-Based 
Typing (SBT) database for Legionella pneumophila (Mentasti and Fry, 2012; Fiore et al., 
1998). 
The need for such a study was eminent especially that previous work in the Microbiology 
Research Laboratory at AQU, showed the abundant prevalence of L. pneumophila in water 
systems in eight hospitals including Makassed hospital in the West Bank, Palestine. 
Microbiological culture as well as molecular testing for Legionella ssp. was performed on 
both water and biofilm samples. We found 8.3% (6/72) prevalence of L. pneumophila in 
the water samples by culture analysis, this percentage increased to 50% (18/36) by PCR. 
As for biofilms, the prevalence of L. pneumophila was higher, 16.8% (192/1136) by 
culture versus 61.3% (84/138) by PCR analysis (Zayed, 2013).  
The Presence of Legionella bacteria in water distribution systems is a serious health risk to 
hospital staff and patients (Fiore et al., 1998), where very high-risk individuals such as 
organ transplant, intensive care (IC), cancer, infant patients and sites that commonly care for 
chronically ill or immunocompromised patients are found (Mercante and Winchell, 2015). 
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In Palestine there are no specific guidelines for protecting patients from exposure to 
Legionella and no routine microbiological testing for Legionella. Thus L. pneumophila 
infections have not been recognized in Palestinian patients prior to this study. Legionella 
identification is hampered by the viable but non- culturable (VBNC) state compounded by 
limited clinical awareness of the disease and unavailable trained personnel in the 
diagnostic laboratories. However, it is well known that LD identification in pneumonia 
cases generally is underestimated due to the failure to diagnose LD in routine practice 
(Steinert et al., 2002). 
Since 2004, respiratory infections are considered as the largest human disease category 
worldwide and one of the leading causes of death.  Legionella is among the top non- 
zoonotic atypical agents of severe respiratory illness, and successful disease resolution 
requires quick treatment together with rapid diagnosis for informed and accurate antibiotic 
management and epidemiological awareness (Mercante and Winchell, 2015). 
We further continued our enquiry to test the prevalence of Legionella in respiratory tract 
secretions in pneumonia patients. A one-year prospective study from September 2014 to 
August 2015 was performed. Sputum and BAL samples were collected from Makassed 
hospital in East Jerusalem since it is the only center that performs bronchoscopy with 
Broncho alveolar lavage (BAL) in the West Bank; patients from all over the West Bank, 
suspected of pulmonary infections who needed bronchoscopy had their BAL samples 
extracted and examined in this medical center, so we considered this center to be 
representative for all the West Bank hospitals. The study was approved by the hospital’s 
ethical committee, and subjects were provided with written informed consent (Appendix A 
). 
Furthermore, even though isolation of L. pneumophila is considered the “gold standard” 
for the diagnosis of LD (Gaia et al., 2003a; Gaia et al., 2005b),  Collected samples (n=195) 
were cultured on GVPC Legionella selective media before DNA extraction. However, the 
culture of 195 respiratory specimens obtained from suspected pneumonia patients seen at 
Makassed yielded only one isolate (previous results at the Microbiology Research 
laboratory at AQU). This result is similar to study in Israel by Mizrahi et al (2015), in 
which was L. pneumophila isolated from only one respiratory sample out of 133 samples, 
This is due to the sensitivity of detection of Legionella by culturing of respiratory 
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specimens which is highly variable, ranging from >10% to 80%, and recovery is dependent 
on the sample type as well as the antibiotic therapy before processing of the samples 
(Feeley et al., 1979). In Palestine the heavy use of antibiotics without prescription is the 
most likely explanation for the very low yield of Legionella by culture. 
 Cultivation independent analysis was performed using 16S rRNA PCR for L. 
pneumophila identification. The use of PCR-based culture-independent methods for the 
Legionella detection is considered necessary and complementary to the traditional culture-
dependent techniques (Fields et al., 2002). PCR techniques using specific primers for the 
identification of Legionella, has the potential to detect infections caused by any Legionella 
species with greater sensitivity than the culture method and provides results within a short 
time (Kahlisch et al., 2010). Thus, in this study, culture-independent methods for 
Legionella detection were used in parallel with the isolation of Legionella by culture.  
Our results show that 44 out of 195 samples (23%) of respiratory tract samples were 
positive for L. pneumophila, Figure 2. This indicates an annual incidence rate of 0.76 in 
100,000,  coincides with many European countries, where Legionnaires’ disease has an 
overall incidence of 1.16 per 100,000 EU population (Phin et al., 2014),  and  the highest 
incident in Europe was in Spain 2.07 per 100,000, followed by France 1.9 per 100,000 in 
2012 (Euro surveillance epidemiological report  (2013). On the other hand. the reported 
crude incidence of LD in the USA increased from 0.39 to 1.15 per 100,000 between 2000 
and 2009, with higher notification rates in the northeastern states than in other states (Phin 
et al., 2014),  In Israel, a crude incidence 0.67 cases/ 100 000 was reported (Moran-Gilad 
et al., 2014). 
When comparing the identification of L. pneumophila in the sputum versus the BAL 
samples, the BAL samples were more sensitive and showed higher percentage of positive 
PCR results (26 out of 74, 35%) whereas sputum samples showed less sensitivity, (18 out 
of 121, 15%), Figure 3.4 and 3.5. Among all potential specimens for culture and analysis, 
sputum is generally most commonly sought, but in significant LD patients the sputum 
production is little or no sputum for analysis (Mercante and Winchell, 2015), in contrast 
BAL sample allow  recovery of both cellular and non-cellular components of the epithelial 
surface of the lower respiratory tract (Goldstein et al., 1990).    
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Meyer et al (2007) reported the BAL’s widespread acceptance as a clinical technique for 
sampling of respiratory secretions with its leukocytes, and also other cellular components 
such as bacteria, and acellular components such as cytokines, viral particles, and microbial 
signatures (e.g., proteins and nucleic acids),  For this the BAL sample could be more 
representative with this component than sputum.  
Department distribution of hospitalized pneumonia patients that were found to be 
Legionella positive by molecular methods (Figure 3.5) shows, the predominant positive 
cases were in Internal Medicine ward with 16 cases (36.3%), then the Pediatric and ICU 
wards with 11 and 10 respectively, in these wards the patients are more susceptible to 
disease.  Susceptibility to disease is associated with smoking, older age, chronic 
cardiovascular or respiratory disease, diabetes, alcohol misuse, cancer (especially profound 
monocytopenia as seen in hairy cell leukemia), and immunosuppression (Phin et al., 2014). 
In Figure (3.6) the majority of L. pneumophila positive patients were under 20 years (15/44 
cases 34%), about 20% of the cases were under 10 years, although we reported 6 cases 
(31.6%) were between 20-40 years, 10 cases (22.7%) were between 41-60 years, and 9 
cases (20.4%) above 60 years. Our results are different from studies which reported the 
incidence of LD in children is rare and most of the cases occur in older people (74–91%)  
patients ≥50 years) (Phin et al., 2014).  Moran-Gilad et al (2014) reported the vast majority 
(86.4%) of cases of LD in Israel occurred amongst patients over 45 years of age, and 
51.7% of cases occurred amongst the 65+ year age group, this difference is due to the most 
of cases under the age of 10 years with recurrent lung infection  and immunodeficiency 
(data not shown).  
Our results showed in table (3.3) the distribution of the L. pneumophila positive samples 
according to gender, twenty two  males were positive out of 120 male patients with 18.3 %, 
in contrast,  twenty two  females were positive out of 75 total females with 29.3%, this 
results showed the incident in females was more than male. In contrast, Globally the gender 
distribution of cases is similar between countries and cases are predominantly in men (1·4–
4·3 male patients for every female patient) (Mercante and Winchell, 2015), In Israel the 
incidence of LD in men was 2.16 per women (Moran-Gilad et al., 2014), Faradonbeh et al 
(2015), reported no statistically significant differences in the incidence of L. pneumophila 
between males and females in Iranian patients.  
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In addition to Legionella detection in clinical material, typing of Legionella strains is of 
considerable importance in determining sources of nosocomially-acquired legionellosis. 
Thus NPSBT was the method to follow in order to be able to perform epidemiological 
typing in the absence of isolates and to try to link the ST’s of the clinical samples with 
ST’s of the environmental samples (Schousboe et al., 2013). 
NPSBT is a discriminatory method to genotype L. pneumophila and can also be used to 
prove correlation between patients and environmental samples. Many studies used NPSBT 
to confirm nosocomial infection caused by Legionella. A study in Geneva, Switzerland 
confirmed two nosocomial infections in 1999 and 2006 by testing three patient samples 
and environmental samples from the same hospital by using SBT method. The SBT 
profiles from clinical and environmental samples were the same in two cases (Schousboe 
et al., 2013). Also in Canada, a 74-year-old woman was admitted to the hospital due to 
myocardial infarction. She was intubated in the emergency room (ER) and then transferred 
to the intensive care unit (ICU), after 10 days she developed pneumonia, and from her 
BAL specimen L. pneumophila was isolated, and she died on day 24 of cardiac 
complications and L. pneumophila was isolated from potable water in the ER and ICU in 
the hospital. The infection was defined as nosocomial, based on the onset and the 
incubation period. But to confirm nosocomial infection SBT was used on patient sample 
and environmental samples from (ER and ICU) and the SBT profile was the same as the 
patient’s SBT, confirming nosocomial infection (Wong et al., 2006). 
Therefore, we adopted a highly discriminatory typing method, NPSBT, to provide useful 
information about the sources of infection particularly because it could be applied in situ as 
no Legionella isolates could be obtained. In this study, we applied NPSBT on clinical and 
presumptively linked environmental samples, in order to look for any correlation and to 
know the sequence type of Legionella trying to demonstrate the source of infection. The 
genetic variability of L. pneumophila has been assessed for countries such as the United 
Kingdom, Belgium, Portugal, Italy, United State, Spain and other countries (Wong et al., 
2006), but there is no similar information available for Palestine. 
Thirty-four L. pneumophila PCR-positive specimens were tested by nested PCR SBT using 
a protocol described previously (Mercante and Winchell, 2015),  
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After submission of data files to the website: 
(www.hpa-bioinformatics.org.uk/cgi-bin/legionella/sbt/seq_assemble_legionella1.cgi) 
 
A full 7-allele profile from the DNA of respiratory tract samples was obtained form 3/34 
(8.8%) specimens, a further 18/34 (53%) specimens gave 5- or 6-allele profiles usually 
sufficient to identify the strain as belonging to one or two sequence types (STs)], 6/34 
(17·6%) gave 3- or 4-allele profiles (usually sufficient to differentiate one profile from 
another without determining their ST, and 7/34 (20.5%) gave 1- or 2-allele profiles for 
which we couldn’t determine the ST (Appendix D). these results are similar a recent to 
study performed in China by Qin et al (2016), where by 44/71 (62%) of samples gave a full 
profile, (33/41 BAL samples, and 11/30 from sputum), and 13 /71 (18.3%) gave 5 to 6 
alleles. 
Four sequence types were identified in the 24 respiratory samples; ST1 (29.1%, 7/21), ST 
461 (25%, 4/21), ST 1037 (4.7% 1/21), and 41.9% incomplete profile.  ST 1 was the most 
predominant sequence type in clinical samples, (Figure3.11). According to several studies 
it appears that the most prevalent ST among clinical and environmental populations of Lp1 
is ST1. However in Belgium and the United Kingdom, the most frequently detected ST 
among clinical isolates is ST47.  Also the most prevalent genotype among clinical Lp1 
isolates in France, the  Netherlands (Kozak-Muiznieks et al., 2014),  and  Italy is ST23 
(Sánchez-Busó et al., 2015).                                                                                                                                                                       
The results of Sequence Types of environmental samples revealed five different sequence 
types (ST 1 (28.5%, 4/14), ST 187 (21.4%, 3/14), one sample of each ST 2070, ST 461 and 
ST 1482 (7.1 %, 1/14), while the rest of samples (21.3%, 3/14) were unspecified Sequence 
types. The most predominant ST in the selected environmental samples is also ST1. This 
result is in correlation with our previous study which included eight hospitals in the West 
Bank, Multiple-Locus Variable number of Tandem Repeats (VNTR) Assays (MLVA)) was 
adopted for genotyping, the most prevalent MLVA8 genotype for this hospital as well as the 
total of hospitals included in the survey, was genotype 4 which corresponds to ST1 (Zayed, 
2013). 
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Worldwide, ST1 is the most predominant ST of L. pneumophila, Kozak-Muiznieks et al 
(2014), reported the most prevalent ST for both clinical sporadic and environmental isolates 
was ST1 and it is the most widespread ST in the world.  
According to the studies of the distribution of Lp1 STs in different regions of the world, it 
appears that the most prevalent ST among clinical and environmental populations of Lp1 is 
ST1 (Kozak-Muiznieks et al., 2014),  Moran-Gilad et al (2014) reported that the ST1 
accounts for 39% of ST1s in the global Legionella database. 
The closely related ST35, ST36, and ST37 are widely distributed in the world and were 
responsible for multiple sporadic cases and outbreaks in the past, including the first 
described outbreak in Philadelphia, Pennsylvania, in 1976 caused by ST36. In contrast, 
ST222 is an emerging strain identified only 14 years ago, which now may be expanding 
from North America to other continents as was hypothesized previously (Kozak-Muiznieks 
et al., 2014). 
ST1 was the cause of multiple outbreaks in Canada and Europe (Kozak-Muiznieks et al., 
2014),  and in many regions of the world. In a recent study in Spain ST1 was the most 
frequently found ST in environmental samples, with 203/643 (31.6%) strains having this 
genetic profile, in agreement with data from previous reports from other areas, however 
ST578 was found to be the second most frequently reported type (65/643; 10.1%) 
(Sánchez-Busó et al., 2015). 
The alleles’ amplification in Nested-PCR of the environmental samples was higher than 
the amplification in clinical samples. This is mostly related to the genomic copies present 
in the sample, where L. pneumophila DNA content is higher in the environmental samples 
than in the respiratory samples. The pilE gene was the gene mostly amplified in the 
respiratory samples, whereas five genes flaA, pilE, asd, mip, and mompS  were equally 
amplified in the environmental samples including pilE gene. 
 
This study demonstrates the advantage of PCR for sensitive detection and identification of 
L. pneumophila in clinical samples by PCR than by culture, particularly, in a country 
where most patients use antibiotics prior to hospital admission, making it difficult to isolate 
L. pneumophila strains from clinical specimens. Another important finding is the 
nosocomial health risk to susceptible patients, since ST 1 was the most predominant ST in 
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both clinical and environmental samples, though we could not verify the source of 
infection with full certainty, the nosocomial threat persists, and sustainable monitoring of 
hospital water systems is demanded. 
 
The monitoring of hospital water systems, by setting a guideline to detect and prevent 
colonization in hospital water system will decrease legionellosis risk in Palestinian 
hospitals. Two studies from Spain show that Legionella colonization was extensive in 
Barcelona hospitals, and that environmental monitoring followed by intensive clinical 
surveillance identified previously unrecognized cases of hospital-acquired LD. After this 
action the effect of this approach recently was evaluated and the results showed a 
significant decrease in the number of health care-associated cases of LD after the 
preventive guideline was in place (Sabrià et al 2004; Squier et al., 2005).  
In conclusion, ST1 was the predominant ST in clinical samples, and the most frequent ST 
in the hospital environmental samples.  ST461 was the second most frequent ST in the 
clinical samples and was also present in the hospital environmental samples. This may 
indicate possible nosocomial infection.  
Regular monitoring and surveillance of hospital water systems for colonization by 
Legionella species should be implemented to lower the risk of nosocomial infections. 
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4.2 Conclusions  
 
1. L. pneumophila serogroup 2-14 was isolated from one out of 195 cultured 
respiratory samples. 
 
2. By using a molecular method (PCR) for detection of Legionella 44/195 (23%) of 
respiratory samples were positive for L. pneumophila, showing that the molecular 
method is much more sensitive than the culture method. The identity of the positive 
samples was confirmed as L. pneumophila by sequencing. 
 
3. BAL samples gave a higher number of positive identification of L. pneumophila by 
PCR than sputum samples. BAL samples are better representation of the microbial 
content of the lung. 
 
4. NPSBT is a high-resolution genotyping method that is very useful when no isolates 
are available, the case that is present in PALESTINE most likely because of the 
heavy use of antibiotics prior to hospitalization. 
 
5.  Four sequence types were identified in the respiratory samples ,with ST 1 being 
the most prevalent. 
 
6.  Five sequence types were identified in the environmental samples ,with ST 1 being 
the most prevalent. 
 
7. There is high likelihood of nosocomial infection of the patients. 
 
 
 
 
 
61 
 
 
4.3 Recommendations 
 
1. Raising awareness regarding the prevalence of Legionella spp. in the water systems 
and in respiratory samples amongst hospital staff and medical teams. 
 
2. Regular surveillance and monitoring of water systems in the hospitals for 
Legionella identification and quantification and management of high prevalence 
when found. 
 
3. The implementation of PCR for the identification of Legionella rather than culture 
 
4.  In hospitals hot water should be maintained above 50°C for reduction of 
Legionella count. 
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Appendix B 
 
Sample ID Sampling date Age Gender Department 
6 20/09/2014 61 years Female ICU 
7 27/09/2014 40 years Female Internal medicine  
8 27/09/2014 70 years Male ICU 
9 27/09/2014 34 months Male Pediatric 
10 27/09/2014 10 years Male Pediatric 
11 27/09/2014 7 months Male Pediatric 
14 27/09/2014 60 years Female ICU 
15 27/09/2014 45 years Male Internal medicine 
16 27/09/2014 6 years Male Pediatric 
17 27/09/2014 65 years Female  Internal medicine 
18 27/09/2014 32 years Male Internal medicine 
44 15-30/10/2014 16 years Male Pediatric 
64 17/11/2014 62 years Male ICU 
75 01/12/2014 55 years Male Internal medicine 
109 15/12/2014 70 years Female ICU 
113 29/12/2014 59 years Female ICU 
116 3/1/2015 36 years Female Gynecology 
117 20/1/2015 49 years  Male Internal medicine 
119 02/02/2015 78 years Male Surgery 
125 10/02/2015 16 years Male Internal medicine 
127 15/02/2015 13 years Female Pediatric 
128 15/02/2015 2 years Male Pediatric 
129 15/02/2015 1 years Female ICU pediatrics 
130 09/02/2015 86 years Male Internal medicine 
131 08/02/2015 15 years Female Pediatrics 
133 29/01/2015 1 years Female ICU pediatrics 
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142 27/02/2015 31 years Female ICU 
144 09/03/2015 3 years Female Pediatrics 
145 09/03/2015 66 years Female Internal medicine 
146 09/03/2015 64 years Female Internal medicine 
148 09/03/2015 45 years Female Internal medicine 
149 09/03/2015 46 years Female Internal medicine 
151 09/03/2015 8 years Female Surgery  
160 15/03/2015 49 years Male ICU 
161 21/04/2015 39 years Female ICU 
171 10/05/2015 34 years Male Surgery 
172 10/05/2015 6 years Male      
Pediatric 
176 31/05/2015 61 years Female Internal medicine 
177 31/05/2015 13 years Male Pediatrics 
186 16/06/2015 48 years Male Internal medicine  
187 11/05/2015 52 years Male Internal medicine 
191 10/06/2015 76 years Female Internal medicine 
192 10/08/2015 68 years Male Surgery 
195 15/08/2015 38 years Female ICU 
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APPENDIX C 
 
 
neupromompmipasdpileFla×band #sample #
×××××××7s (218)
××2S1 (125)
×××××5S2 (145)
×××××5S3 (146)
×1S4 (147)
×××3S5 (117)
×××××××7S 6 (144)
×××2S7 (109)
××××5S8 (142)
×××××5S9 (148)
×××××5S10 (149)
×××3S11 (171)
×××4S12 (172)
×1S13 (176)
×1S14 (177)
××××4S15 (195)
××××4S16 (160)
0S17 (161)
××××××6S18 (130)
×××××5S19 (131)
××××××6S20  (75)
×××××5S21(145)
××××××6S22(186)
×××3S23(187)
××××××6S24(44)
0S25(133)
××××××6S26(10)
×××××5S27(151)
×××××5S28 (11)
××××××6S29(14)
×××××5S30(15)
××××××6S31(16)
×××××××7S32 (17)
××××××6S33(18)
Number of positive alleles in respiratory  samples
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neupromompsmipasdpilEflaband #collection Sample
×××××××78 thM 1
×××××××78thM 3
×××××××78thM 4
×××××××78thM 5
×××××××78thM 7
×××××××78thM H
×××××××79thM 6
×××××××79thM 8
××××××69thM 13
×××××××79thM 5
07thM 1
××××××67thM 3
×××××××77thM 4
×××××××77thM 7
×××××××77thM C
Number of positive alleles in environmental samples
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Appendix D 
NPSBT alleles and sequence types ( respiratory samples) 
Sample Fla pilE asd mip momps proA neuA ST 
S0 1 4 3 1 1 1 1 ST 1 
S2 6 0 0 28 0 14 0 ST 461 
S3 6 0 0 0 21 4 9 ST 1037 
S6 6 10 14 30 21 1 1 ST 461 
S8 1 0 0 0 1 0 0 ST 1 
S9 6 0 11 0 1 0 9 ST461 
S10 0 0 3 28 0 0 1 N/D 
S12 0 0 0 0 1 0 0 N/D 
S15 0 0 3 0 1 0 0 N/D 
S16 4 7 14 0 0 0 0 N/D 
S18 1 4 3 0 1 1 1 ST 1 
S19 1 4 3 1 0 0 0 ST 1 
S20 1 10 14 0 1 1 1 N/D 
S21 6 0 0 1 0 14 9 ST 461 
S22 1 0 0 1 1 1 1 N/D 
S24 1 4 3 1 1 1 0 ST 1 
S26 1 10 3 0 1 1 1 N/D 
S27 6 4 0 28 0 1 1 ST 461 
S28 6 0 3 1 21 0 0 N/D 
S29 1 4 14 1 21 1 0 N/D 
S30 1 4 3 1 0 1 0 ST 1 
S31 1 10 3 0 21 1 0 N/D 
S32 1 4 3 1 1 1 1 ST 1 
S33 6 0 3 1 0 14 9 ST 461 
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NPSBT alleles and sequence types (environmental samples) 
Sample 
ID 
Collection
Number 
Ward flaA pilE asd mip mompS proA neu ST 
M 1 7
th
  0 0 0 0 0 0 0  
M 3 7
th
 Internal medicine  3 10 1 0 0 0 0 ST187 
M 4 7
th
 ICU Pediatric 1 4 1 1 0 0 0 ST 1 
M 7 7
th
 Neonate  1 4 11 1 0 1 0 N/D 
M C 7
th
 General cold water 1 7 5 1 0 9 0 N/D 
M1 8
th
       ICU 1 4 3 1 0 1 0 ST 1 
M 3 8
th 
Pediatrics 1 4 3 1 0 1 0 ST 1 
M 4 8
th
 Internal medicine 0 10 0 0 0 1 0 ST 2070 
M 5 8
th
 Internal medicine  2 4 0 28 0 1 0 N/D 
M 7 8
th
 Surgery 3 10 1 0 0 1 0 ST 187 
M H 8
th
 General hot water  1 4 0 0 0 0 0 ST 1 
M 5 9
th 
Internal medicine  3 10 1 0 0 0 0 ST 187 
M 6 9
th
 ICU 7 10 0 0 0 0 0 ST 1482 
M 8 9
th
 ICU Pediatric 6 10 14 0 0 0 0 ST 461 
M 13 9
th
 Arthroscopy         N/D 
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Appendix E 
Sequencing of Seven alleles for sample S0 (218)  
> Seq0-flaA-F 
GGTAANATTCTCGATGGCTCTTTCTCTGGTGCAAGCTTCCAGGTTGGAGCGAATTCAAACCAAACCATCAAT
TTCAGTATCGGCAGCATAAAAGCTTCTTCCATTGGTGGTATTGCCACGGCAACAGGAACAGAAGTAGCTGG
TGCAGCAGCGACAGATATCACTATCGCAATTGGAGGAGGAGCAGCAACCAGTATTAACTCTTCTGCCAATT
TTACCGGGGCACTAAACGGGCAAGATGCTACGTCTGCCTATGCCAAAGCAGCGGCTATCAACGATGCCGG
GATAGGAGGACTATCAGTTACAGCATCTACCAGCGGCACACAAGCAGTTGGCGCAATAGGTGGAACCAGC
AGGTGATACCA 
 
> seq0-flaA-R 
TGNNCNTGCTTGTGTGCCGCTGGTAGATGCTGTAACTGATAGTCCTCCTATCCCGGCATCGTTGATAGCCG
CTGCTTTGGCATAGGCAGACGTAGCATCTTGCCCGTTTAGTGCCCCGGTAAAATTGGCAGAAGAGTTAATA
CTGGTTGCTGCTCCTCCTCCAATTGCGATAGTGATATCTGTCGCTGCTGCACCAGCTACTTCTGTTCCTGTTG
CCGTGGCAATACCACCAATGGAAGAAGCTTTTATGCTGCCGATACTGAAATTGATGGTTTGGTTTGAATTC
GCTCCAACCTGGAAGCTTGCACCAGAGAAAGAGCCATCGAGAATTCTTTGACCATTGAATTCAGTATTTTG
AGCAATACGCAC  
>seq0-pilE-F 
GNTTCATCGCTTCCNACATNACGCCAGNAAAATAGGCTTGGTTGGCAAATTTCAATAGAGGATACCCAAAT
GCTCAGTCATGTACATTTTTATGAAGAATAGCCGTATGAAACAATCCGCGTTTACCCTGGTTGAAGTTCTGA
TCAGCATGGTCATTATGGGCATTCTGGTTTCAATTGCCTATCCATCCTATTTACAATATATCCAAAAATCCCG
TCGTGCCGATGCTCACGCCACATTGACACAAGATCAAATTATTTTAGAACGCTGTTATTCACAGAATTTTTCT
TATGCTGCGGCGTGTGGCGCCTTACCAGCATTTCCTCAAACAACGCCGAACGGGTACTATACTATCAATATT
TCAAACCTGACAGCCACAACGTATACCTTAACTGCAACCCCTGTTGGAACTCAAGCCAAAGATACCGAGTG
CGCCACCATTGTCTTTTAACCGGGCCAATGTACCACCCCCTGTAGATTCCTCGGCAAGGCCG 
>seq0-PilE-R 
TANTCAGNAACAACGGGGCCGCAGTCAAGGTATACGACGCGGCAGTCGGTCTGAAATATTGATAGTATAG
TACCCGTACGGCGTTGTTTGAGGAAATGCTGGTAAGGCGCCACACGCCGCAGCATAAGAAAAATTCTGTG
AATAACAGCGTTCTAAAATAATTTGATCTTGTGTCAATGTGGCGTGAGCATCGGCACGACGGGATTTTTGG
ATATATTGTAAATAGGATGGATAGGCAATTGAAACCAGAATGCCCATAATGACCATGCTGATCAGAACTTC
93 
 
 
AACCAGGGTAAACGCGGATTGTTTCATACGGCTATTCTTCATAAAATGTACATGACTGAGCATTTGGGTATC
CTCTATTGAATTTGCCACCAGCCTATTTTTCTTGGCGTAATGTTAGGAGCGATAACAGTAGTTTGTGTTCCAT
CCGATTGTGAGGAAGTAACCAGNTTAATTCCNTCCCTGCCGGNCN 
 
 
>seq0-asd-F 
CCCNNCGCATATAGCAATCCANGACGCCGTCGGCATAAGATCGTATCAAAGCGGCGACTAACCAGCCTGT
TTCCGGGACTGGCAAAAAAGCCATCAGCGAACTGGTCGCTCAGGTAGGCGATCTTTTAAATGGGAGACCA
GCTAATGTTCAAGCCATCCTCAGCAAATCGCTTTTAATGCGCTTCCTCATATTGATCAGTTCGAAGACAATG
GTTATACCCGGGAAGAGATGAAGATGGTCTGGGAAACCCGCAAGATTATGGAAGATGACAGCATTATGGT
TAACCCTACAGCTGTCAGGGTTCCCGTTATTTATGGGCATTCTGAAGCGGTTCATCTGGAATTAAAAAAGCC
TTTGACGGCTGACGATGCTCGCGCGCTTTTGGCAAAGGCACCCGGCGTTACTGTAGTGGATAATCTTTCTA
AAGCAAGTTATCCCACAGCAATTAAGAATGCAGTTGGGCATGATGATGTTTTTGTAGGGCGCATAAGACAG
GATATTTCTCATCCTTGTGGACTAAATTTGTGGATAGTCGCAGATAACATTCGA 
 
>seq0-asd-R 
AAAANCACAAGGAAGAGAAATCCTGTCTAATGCGCCCTACAAAAACATCATCATGCCCAACAGCATACTAA
ATAGCTGTGGGATAACTAGCTTTAGAAAGATTATCCACTACAGTAACGCCGGGTGCCTTTGCCAAAAGCGC
GCGAGCATCGTCAGCCGTCAAAGGCTTTTTTAATTCCAGATGAACCGCTTCAGAATGCCCATAAATAACGG
GAACCCTGACAGCTGTAGGGTTAACCATAATGCTGTCATCTTCCATAATCTTGCGGGTTTCCCAGACCATCT
TCATCTCTTCCCGGGTATAACCATTGTCTTCGAACTGATCAATATGAGGAAGCGCATTAAAAGCAATTTGCT
GAGGATAGACTTGAACATTAGCTGGTCTCCCATTTAAAAGATCGCCTACCTGAGCAACCAGTTCGCTGATG
GCTTTTTTGCCAGTCCCGGAAACAGACTGGTAAGTCGCCACATTAATACGACTAATACCAACAGCGTCATA
GATTGGCTTTAGAGCAACGACCATCTGANNNNTAGAGCAATTAGGG 
 
>seq0-mip-F 
NACANNAGATAGGAAAGACGNCAAAAAGCACAGGAGCCGATACGGGGAAGAAACAAAAAATAAGGCAT
AGAAGATAATCCGGAAGCAATGGCTAAAGGCATGCAAGACGCTATGAGAGGCGCTCAATAGGCTTTAACC
GAACAGCAAATGAAAGACGATCTTAACAAGATTCAGAAAGATTTGATGGCTAAGCGTACTGCTGAATTCAA
TAAGAAAGCGGATGAAAATAAAGTAAAAGGGGAAGCCTTTTTAACTGAAAACAAAAACAAGCCAGGCGTT
GTTGTATTGCCAAGTGGTTTGCAATACAAAGTAATCAATTCTGGAAATGGTGTTAAACCCGGAAAATCGGA
TACAGTCACTGTCGAATATACTGGTCGTCTGATTGATGGTACCGTTTTTGACAGTACCGAAAAAACTGGTAA
GCCAGCAACGTTCCAGGTTTCACAAGTTATCCCTGGATGGACAGAAGCTTTGCAATTGATGCCAGCTGGAT
CAACTTGGGAAATTTATGTTCCCTCAGGTCTTGCATATGAATGA 
>seq0-mip-R 
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CAANNAGANAGAACAGCCGGCATAACCGCAAAGCAACCGACCCCCAGGGAAACCCGCGAAACCCGGAAC
GACGCCGGCAAACCAGAAAAAACGGAACCGACAAAAACGGAACCAACAAACAGACGACCAGAAAACACG
ACAGCGACAGCATCCGATAACCCGGGCCTAACACCATCACCAGAATAGATCACTCTGTATCGCAAACCACT
CGGCAATACAACAACGCCTGGCTTGTTTTTGTTTTCAGTTAAAAAGGCTTCCCCTTTTACTTTATTTTCATCCG
CTTTCTTATTGAATTCAGCAGTACGCTTAGCCATCAAATCTTTCTGAAACTTGTTAAGAACGTCTTTCATTTG
CTGTTCGGTTAAAGCCAATTGAGCGCCACTCATAGCGTCTTGCATGCCTTTAGCCATTGCTTCCGGATTAAC
ATCTATGCCTTGATTTTTAAAATTCTTCCCCAAATCGGCACCAATGCTATAAGACAACTTATCCTTGTCTGTA
GCTAATGATGTGGCATCGGTGGCAGCA 
 
>seq0-mompS-F 
GTANGACGTTGANANATGGGCATGANTTTTGCTAACTTGGCACAACTACAACAACAAGAGGGATGCTGTT
AATGCTGAATAAGGTCAATACGTAGATTTCAGCGCTAACAAGAAAATGCGATTCCACGGCGGTGTTCAATA
CGCTCGCATTGAAGCTGATGTGAACCGTTATTTCAATAACTTTGCCTTTAACGGGTTCAACTCTAAGTTCAAT
GGCTTTGGTCCTCGCACTGGTTTAGACATGAACTATGTATTTGGCAATGGCTTTGGTGTTTATGCTAAAGGC
GCTGCTGCTATTCTGGTTGGTACCAGCGATTTCTACGATGGAATCAACTTCATTACTGGTTCTAAAAATGCT
ATCGTTCCTGAGTTGGAAGCTAAGCTTGGTGCTGATTACACTTACGCAATGGCTCAAGGCGATTTGACTTTA
GACGTTGGTTACATGTGGTTTAACTACTTCAACGCTATGCACAATACTGGCGTATTTAATGGATTTGAAACT
GATTTCGCAGCTTCTGGTCTG 
 
>seq0-mompS-R 
TTANCTTANAACGCCGTTATCTGTGCATAGCGTTGAAGTAGTTAAACCACATGTAACCAACGTCTAAAGTCA
AATCGCCTTGAGCCATAGCGTAAGTGTAATCAGCACCAAGCTTAGCTTCCAACTCAGGAACGATAGCATTTT
TAGAACCAGTAATGAAGTTGATTCCATCGTAGAAATCGCTGGTACCAACCAGAATAGCAGCAGCGCCTTTA
GCATAAACACCAAAGCCATTGCCAAATACATAGTTCATGTCTAAACCAGTGCGAGGACCAAAGCCATTGAA
CTTAGAGTTGAACCCGTTAAAGGCAAAGTTATTGAAATAACGGTTCACATCAGCTTCAATGCGAGCGTATT
GAACACCGCCGTGGAAACGCATTTTCTTGTTAGCGCTGAAATCTACGAATTGACCTAATTCAGCATTAACAG
CATCCCACTTGTTGTTGTAGTTGTGCCAGTTAGCAAAATCAGCCCAGTGATCACTGTCATTATCAAAATGAT
ACCAGTTCACATTGATGTCA 
 
>seq0-proA-F 
CGAGCACAGGTTANGGCTATGAAAACGCCNACAGGGACGGCAAGCAAACGACCACCGGCGAGGCGACAC
CACGACGAAACCAACGGAAACTCAAGGCGAAGGCGGACAAGAAGAAAGCCAAGGAAACACAGAACAAC
AAACTGGACAAGAATATAACGGACAGACTGGAGGCATGAATGAGACGTATTCAGATATGGCTGCTCAAGC
TGCTGAATATTATTCAGTCGGAAAAAACAGCTGGCAGATCGGCCCGGAAATAATGAAAGAAGACAGTGGT
TATGACGCATTGCGTTACATGGATAAACCAAGCCGTGATGGTATGTCTATTGATGTAGCTGATGATTATTAT
GGCGGGTTAGATGTTCATTACTCCAGTGGAGTGTATAACCATTTATTCTACATATTAGCTAATCAACCTAAT
TGGAATCTTCGTATGGCTTTTGATTTATGGTAAAGGCTAGTTTACATTATTTTACACCTTATTCAACATTTGA
TGAGGGTGGTTGCGTTGTGTTNATT 
95 
 
 
 
>seq0-proA-R 
AATATCATAGGANTGANCAGCTAATACGNAGAATAAACGGAAATACACTCCACCGGAGCAATGAACATCT
AACCCGCCATAATAATCATCAGCAACATCAATAGACAAACCATCACGGCTAGGAATATCCATGAAACGCAA
TGCGTCATAACCACTGTCTACTATCATAATTTCCGGGCCGATCTGCCAGCTGTTTTTTCCAACTGAATAATAT
TCAGCAGCTTGAGCAGCCATATCTGAAAACGACTCATTCATGCCACCAGACTGACCGAAATATTCAAGTCC
AGAATGTTGTTCAGTGAATCCATGGCTAACTTCATGACCACCTACACCTAGAGAAACCAAAGGATACATCA
TGGTGTCACCATCACCAAAGGTCATTTGCTTGCCGTCCCAGTAGGCGTTTTCATAGCCTTGACCATAATGCA
CTCGCATAACTAATTGCATTGGCGATCA 
 
>seq0-neu-F 
CTTGNANNAACGGANAACAAGCCCGGAACTATCGGAAGATGATATCATACTGTTATAGACCTCCTGATAA
GAATCAGCAAATGGATGTTTTTTTTGACAGTGTATTGCTGTTACAACCAACTTCTCCATTTAGGAAGCCAGA
AACCATAAGACATGCTGTTGAAATACATAAAGTAACGGGGAAAAGTGTCGTTTCAGTTAGTCCCATCTCTTT
AAAGCCTTCTTGGTGTAAAAGCATTGATAGCCAAGGCAATTTGGTTAAGCCAGAACTTTTTCAGGATCTGG
AAATTTATTGCAACGAGAATCCAATTTATAAATTAAATGGGTCAATTTATATTGCAACAGCTAAACAAATTA
TTGAAAATAAGAGTTTTTATAGCGAACCAACCAAACCTTTATTGTTAAATAGTATTAGTGAATCCATCAAAC
CCCCATCAATTGGTCTATTGATTAAAAAAAAAAAAAAAAA 
 
>seq0-neu-R 
ACAAAAGGCCCGGATNGGTTCGCTATAAAAACTCTCATCCTCATAATCCGTCTAGCTGTTGCAATATAAATC
GACCCATCTAATCTATAAATCGGATTCTCGTTGCAATAAATCTCCAGATCCTGAAAAAGTTCTGGCTTAACC
AAATTGCCTTGGCTATCAATGCTTCTACACCAAGAAGGCTTTAAAGAGATGGGACTAACTGAAACGACACT
TTTCCCCGTTACTTTATGTATTTCAACAGCATGTCTTATGGTTTCTGGCTTCCTAAATGGAGAAGTTGGTTGT
AACAGCAATACACTGTCAAAAAAAACATCCATTTGCTGAAACTTAAACAGGAGGTCAATAACAGTATGAAT
CACATCCGAAGTATCCGTGGCTAAATCTTCCGATCTTAGCCAGGGTACTGAAGCCCCATATCCAACGGATTG
GGTCTGCAAAAAATAAAAAAATCGGTTGATTCAACCATTTCTTCGCAACGGGACGACTGCAAGGNGGACTC
A 
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 desaB ecneuqeS والتصنيف القبئم على التسلسل الجيني  noitacifitnedI raluceloMالكشف الجزيئي 
 في العينبث البيئيت والسريريت في فلسطين alihpomuenp allenoigeLلبكتيريب الليجيونيلا نيوموفيلا  gnipyT
 
 
 اعداد : محمود جميل عمرو
 اشراف: الدكتورة دينب البيطبر
 
زد على ذلك ان اللجٌونٌلا من البكتٌرٌا التً تصعب زراعتها  , هً البكتٌرٌا سالبة الجرام، تكون اسطوانٌة الشكل  الٌجٌونٌلا
) و تسبب أنواع اللٌجٌونٌلا فً متلازمٌن سرٌرٌٌن: مرض الالتهاب الرئوي اللٌجونٌلً  )suoiditsafفهً بطٌئة النمو 
).  )sisollenoigel)، التً تعرف مجتمعة باسم الفٌلق revef caitnoP)، وحمى بونتٌاك ( esaesid ’serannoigel(
هً    اalihpomuenp allenoigeLفصٌلة من أنواع اللٌجٌونٌلا، فإن اللٌجٌونٌلا نٌوموفٌلا  07نوعا و  25ومن بٌن 
ً النمط المصلً ه 1٪) من ضمن جمٌع الانواع، والمجموعة المصلٌة 5.19المسبب الرئٌسً لداء الالتهاب الرئوي بنسبه (
 .٪)2.48السائد بنسبه (
 
وقد أظهرت العدٌد من الدراسات أن المصدر الرئٌسً لهذه البكتٌرٌا  هو أنظمة المٌاه الصالحة للشرب فً المبانً الكبٌرة مثل 
مراض المستشفٌات والفنادق. تلوث شبكات المٌاه بالمستشفٌات مع اللٌجٌونٌلا هو خطر كبٌر للمرضى الذٌن ٌعانون من أ
مرضى الذٌن ٌعانون من نقص فً المناعة ومن أولئك الذٌن قد ٌقٌمون  فً المستشفى لفترة طوٌلة من المختلفة، وخاصة 
 الزمن. ٌتم الحصول على الالتهاب الرئوي اللٌجونٌلً  من خلال استنشاق قطرات صغٌرة من الماء  الملوثة مع اللٌجٌونٌلا . 
دراسة سابقة فً مختبر أبحاث المٌكروبٌولوجً فً جامعة القدس أن  انتشارا كبٌرا لبكتٌرٌا الٌجٌونٌلا فً عٌنات  توقد أظهر
، 4102إلى دٌسمبر  2102المٌاه  التً تم جمعها من ثمانٌة مستشفٌات فً الضفة الغربٌة على مدى فترة سنتٌن من دٌسمبر 
) (sisylana tnednepedni noitavitlucو   dohtem  tnedneped erutlucوذلك باستخدام أسلوب التقلٌدي 
علاوة على ذلك دراسة وكشف عن   ANRr S61للحمض النووي والذي ٌستهدف جٌن (RCP)باستخدام التفاعل التسلسلً 
 erutlucمن عٌنات الجهاز التنفسً من خلال استخدام الطرق التقلٌدٌة ( 591بكتٌرٌا اللٌجٌونٌلا  نٌوموفٌلا فً 
عٌنه فً حٌن أظهرت النتائج ارتفاع  591والتً اعطت عن عٌنة إٌجابٌة واحدة من ضمن     dohtem  tnedneped
) باستخدام طرق الكشف الجزٌئٌة 591/44٪ (32معدل انتشار ووجود هذه البكتٌرٌا فً عٌنات الجهاز التنفسً إٌجابٌة 
 ANRr S61التً تستهدف جٌن  RCPالتسلسلً   عن طرٌق استخدام التفاعل  seuqinhcet raluceloM
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التشخٌص عن بكتٌرٌا اللٌجٌونٌلا  باستخدام طرق الكشف الجزٌئٌة  تطورت فً أنحاء العالم لأن طرق الكشف التقلٌدٌة تحتاج 
من أجل للٌجٌونٌلا نٌوموفٌلا مهم بشكل كبٌر     cipytonegوقت كبٌر وقلٌلة الكفاءة. ومن ناحٌه أخرى التصنٌف الجٌنً 
 الدراسات الوبائٌة و التحكم واحتواء انتشار مرض الفٌلق.
  والأسالٌب المعتمدة حالٌا فً التصنٌف الجٌنً لهذه البكتٌرٌا مبنً على التفاعل التسلسلً والتصنٌف من خلال تسلسل جٌنات
ه النوع التسلسلً لبكتٌرٌا الذي ٌقوم على أساس معرفه تسلسل سبعه من الجٌنات وهذه الطرٌقة تمكن من معرف  )TBSPN(
فً التصنٌف الجزٌئٌة موصى بها من قبل  الدقة عالٌةالٌجٌونٌلا نٌوموفٌلا فً حاله عدم وجود عزلات بكتٌرٌة. هذه الأداة 
  ILGWEمجموعه العمل الأوروبٌة لعدوى اللٌجٌونٌلا 
  
بنٌوموفٌلا فً عٌنات الجهاز  .رٌا الٌجٌونٌلاوكان الهدف العام من هذه الدراسة هو تحدٌد ومعرفة النوع التسلسلً لبكتٌ
من  TS(. وأٌضا لتحدٌد النوع التسلسلً ( TBSPNالتنفسً من المرضى المصابٌن بالالتهاب الرئوي اللٌجونٌلً، باستخدام 
 .التً تم الحصول علٌها من اجنحة  المستشفى نفسه    mlifoiBعٌنات المٌاه  و الغلاف الخلوي
عٌنات تنفسٌة تم اختبارها وتحلٌلها وكانت إٌجابٌة لوجود هذه البكتٌرٌا  44عٌنة) من أصل  43(وشملت الدراسة على 
. وقد تم تقسٌم وتصنٌف هذه العٌنات الأربعة ANRr S61) الذي ٌستهدف جٌن RCPباستخدام التفاعل التسلسلً (
ٌنات مٌاه وغلاف خلوي من الدراسة عٌنه من ع 51. وتم ادخال واضافه TBSPNوالثلاثٌن بشكل إضافً بواسطة طرٌقة 
السابقة التً تم جمعها سابقا من أجنحة مستشفى المقاصد وكانت إٌجابٌة للٌجونٌلا  نٌوموفٌلا وتم تحلٌلها أٌضا من خلال 
 TBSPN
 
من عٌنات الجهاز التنفسً باستخدام التفاعل التسلسلً للتصنٌف المبنً على الترتٌب التسلسلً  43من خلال تحلٌل 
٪) حصلنا 9.25أخرى ( 43/81) كامله ، و من  elellAالٌل ( 7٪) من العٌنات على 8.8( 43/3, حصلنا من TBSPN
 elellA (ألٌل ( 4أو  3٪) على  6.71) (43/6(كافٌة لتحدٌد الصنف ) واٌضا حصلنا من ( )elellA (ألٌل  6أو  5على  
 الٌل.  2أو  -1٪) أعطى 7.41( 43/5(عادة ما ٌكفً للتمٌٌز بٌن التشكٌلات المختلفة)، و 
٪) من العٌنات )، ومع ذلك، 07ألٌلات فً ( 7و  6، 5، 4(  )elellA (ألٌل 4من مجموع العٌنات حصلنا على اكثر من  
 .) RCPسل الحمض النووي (عٌنات اقل من اربع  ألٌلز ، تم استبعاد هذه العٌنات من فحص تسل 01أعطت 
السبعة "من عٌنات المٌاه ومسحات الغلاف الخلوي الخمسة عشر المختارة كشفت أربعة   )selellA (ومن  تحلٌل الألٌلات
عشر عٌنة إٌجابٌة لستة إلى سبعة ألٌلات وكانت عٌنة واحدة إٌجابٌة لألٌل واحد، تم استبعاد هذه العٌنة من تسلسل الحمض 
 النووي.
 1النوع التسلسلً   :عٌنه من  عٌنات جهاز التنفسً الانواع التسلسلٌة التالٌة 42ر تحلٌل تسلسل الحمض النووي ل وأظه 
% , 52من العٌنات بنسبة  42/6)  ظهر فً 164TS( 164% ،و النوع التسلسلً 1.92بنسبه  42/7) ظهر فً 1TS(
٪ من العٌنات اعطت انواع 6.14%,  و 4بنسبة )  ظهر فً عٌنه واحده  7301TS( 7301واٌضا النوع التسلسلً 
 تسلسلٌة غٌر مكتملة.
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%,   4.82من العٌنات بنسبه  41/4)  فً  1TS( 1عٌنة بٌئٌة :حصلنا على النوع التسلسلً  41من ناحٌة أخرى، أظهرت 
نوع التسلسلً  % , وفً عٌنة واحدة حصلنا على ال4.12من العٌنات بنسبة  41/3) فً  781TS( 781والنوع التسلسلً  
٪)، فً حٌن أن بقٌة العٌنات 1.7) بنسبة (2841TS( 2841) و النوع   164TS( 164) ، والنوع    0702TS(0702
 .) لم تكن محددة الأنواع التسلسلٌة41/4٪، 5.82(
البٌئٌة التً تمثل  هو النوع الأكثر انتشارا فً كل من عٌنات الجهاز التنفسً والعٌنات )1TS( 1وبالتالً فإن النوع التسلسلً 
 ٪ على التوالً. وٌعتبر هذا النوع التسلسلً هو الاكثر انتشارا على مستوى العالم.5.82٪ و 33
 
